株探米国株
英語
エドガーで原本を確認する
000138561312/312024Q2falseP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureglre:segment00013856132024-01-012024-06-3000013856132024-08-0200013856132024-06-3000013856132023-12-3100013856132024-04-012024-06-3000013856132023-04-012023-06-3000013856132023-01-012023-06-300001385613us-gaap:CommonStockMember2024-03-310001385613us-gaap:CommonStockMember2023-03-310001385613us-gaap:CommonStockMember2023-12-310001385613us-gaap:CommonStockMember2022-12-310001385613us-gaap:CommonStockMember2023-04-012023-06-300001385613us-gaap:CommonStockMember2024-01-012024-06-300001385613us-gaap:CommonStockMember2023-01-012023-06-300001385613us-gaap:CommonStockMember2024-06-300001385613us-gaap:CommonStockMember2023-06-300001385613us-gaap:AdditionalPaidInCapitalMember2024-03-310001385613us-gaap:AdditionalPaidInCapitalMember2023-03-310001385613us-gaap:AdditionalPaidInCapitalMember2023-12-310001385613us-gaap:AdditionalPaidInCapitalMember2022-12-310001385613us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001385613us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001385613us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001385613us-gaap:AdditionalPaidInCapitalMember2023-01-012023-06-300001385613us-gaap:AdditionalPaidInCapitalMember2024-06-300001385613us-gaap:AdditionalPaidInCapitalMember2023-06-300001385613us-gaap:RetainedEarningsMember2024-03-310001385613us-gaap:RetainedEarningsMember2023-03-310001385613us-gaap:RetainedEarningsMember2023-12-310001385613us-gaap:RetainedEarningsMember2022-12-310001385613us-gaap:RetainedEarningsMember2024-04-012024-06-300001385613us-gaap:RetainedEarningsMember2023-04-012023-06-300001385613us-gaap:RetainedEarningsMember2024-01-012024-06-300001385613us-gaap:RetainedEarningsMember2023-01-012023-06-300001385613us-gaap:RetainedEarningsMember2024-06-300001385613us-gaap:RetainedEarningsMember2023-06-3000013856132023-06-3000013856132022-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-01-012024-06-300001385613glre:SolasglasInvestmentsLPSILPMemberus-gaap:SubsequentEventMember2024-08-012024-08-010001385613glre:GreenlightCapitalReLimitedPartnersMemberglre:SolasglasInvestmentsLPSILPMember2024-06-300001385613glre:GreenlightCapitalReLimitedPartnersMemberglre:SolasglasInvestmentsLPSILPMember2023-12-310001385613glre:SILPGeneralPartnerMember2024-06-300001385613glre:SILPGeneralPartnerMember2023-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-06-300001385613glre:SolasglasInvestmentsLPSILPMember2023-12-310001385613glre:SolasglasInvestmentsLPSILPMember2024-04-012024-06-300001385613glre:SolasglasInvestmentsLPSILPMember2023-04-012023-06-300001385613glre:SolasglasInvestmentsLPSILPMember2024-01-012024-06-300001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-06-300001385613glre:SolasglasInvestmentsLPSILPMember2024-04-012024-06-300001385613glre:SolasglasInvestmentsLPSILPMember2023-04-012023-06-300001385613glre:SolasglasInvestmentsLPSILPMember2024-01-012024-06-300001385613glre:SolasglasInvestmentsLPSILPMember2023-01-012023-06-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2024-06-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2024-01-012024-06-300001385613glre:DebtAndConvertibleDebtSecuritiesMember2024-06-300001385613glre:DebtAndConvertibleDebtSecuritiesMember2024-01-012024-06-300001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2023-12-310001385613glre:PrivateInvestmentsAndUnlistedEquitySecuritiesMember2023-01-012023-12-310001385613glre:DebtAndConvertibleDebtSecuritiesMember2023-12-310001385613glre:DebtAndConvertibleDebtSecuritiesMember2023-01-012023-12-3100013856132023-01-012023-12-310001385613us-gaap:FairValueMeasurementsNonrecurringMember2024-06-300001385613us-gaap:FairValueMeasurementsNonrecurringMember2023-06-300001385613glre:TrustAccountsMember2024-06-300001385613glre:TrustAccountsMember2023-12-310001385613glre:CashCollateralLettersofCreditIssuedMember2024-06-300001385613glre:CashCollateralLettersofCreditIssuedMember2023-12-310001385613glre:CashSecuringLoanFacilityMember2024-06-300001385613glre:CashSecuringLoanFacilityMember2023-12-310001385613glre:OtherCashAndCashEquivalentsMember2024-06-300001385613glre:OtherCashAndCashEquivalentsMember2023-12-310001385613us-gaap:FairValueMeasurementsNonrecurringMember2023-12-310001385613glre:MeasurementPeriodOneMember2024-06-300001385613glre:MeasurementPeriodTwoMember2024-06-300001385613glre:MeasurementPeriodThreeMember2024-06-300001385613glre:CATLossesMember2024-01-012024-06-300001385613glre:BaltimoreBridgeCollapseSevereUSTornadosSatelliteFailuresMexicanStateOwnedOilPlatformFireMember2024-01-012024-06-300001385613glre:CATDevelopmentMember2024-01-012024-06-300001385613glre:CATLossesMember2023-01-012023-06-300001385613glre:TurkeyEarthquakeNewZealandCycloneGabrielleSevereU.S.TornadosMember2023-01-012023-06-300001385613glre:CATDevelopmentMember2023-01-012023-06-300001385613Newly Reported Loss2024-01-012024-06-300001385613Favorable Loss2024-01-012024-06-300001385613Reserve Strengthening2023-01-012023-06-300001385613Expected Loss2023-01-012023-06-300001385613glre:RetrocessionPortfolioMemberglre:AOrBetterByA.M.BestMember2024-06-300001385613glre:RetrocessionPortfolioMemberglre:AOrBetterByA.M.BestMember2023-12-310001385613glre:RetrocessionPortfolioMemberglre:NotRatedMember2024-06-300001385613glre:RetrocessionPortfolioMemberglre:NotRatedMember2023-12-310001385613glre:RetrocessionPortfolioMember2024-06-300001385613glre:RetrocessionPortfolioMember2023-12-310001385613glre:ThreeReinsurersMemberglre:ReinsuranceConcentrationRiskMemberglre:TotalLossAndLossAdjustmentExpenseRecoverabilityMember2023-01-012023-12-310001385613glre:ThreeReinsurersMemberglre:ReinsuranceConcentrationRiskMemberglre:TotalLossAndLossAdjustmentExpenseRecoverabilityMember2024-01-012024-06-300001385613glre:TermLoanMember2024-01-012024-06-300001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankEuropePlcMember2024-06-300001385613glre:CIBCBankUSACIBCLOCMemberus-gaap:FinancialStandbyLetterOfCreditMember2024-06-300001385613us-gaap:FinancialStandbyLetterOfCreditMember2024-06-300001385613us-gaap:FinancialStandbyLetterOfCreditMemberglre:CitibankEuropePlcMember2024-04-120001385613us-gaap:CommonClassAMember2022-12-310001385613us-gaap:CommonClassBMember2022-12-310001385613us-gaap:CommonClassAMember2023-01-012023-06-300001385613us-gaap:CommonClassBMember2023-01-012023-06-300001385613us-gaap:CommonClassAMember2023-06-300001385613us-gaap:CommonClassBMember2023-06-3000013856132024-05-030001385613glre:PerformanceRestrictedStockMember2022-12-310001385613glre:ServiceRestrictedStockMember2022-12-310001385613glre:PerformanceRestrictedStockMember2023-01-012023-06-300001385613glre:ServiceRestrictedStockMember2023-01-012023-06-300001385613glre:PerformanceRestrictedStockMember2023-06-300001385613glre:ServiceRestrictedStockMember2023-06-300001385613glre:PerformanceRestrictedStockMember2023-12-310001385613glre:ServiceRestrictedStockMember2023-12-310001385613glre:PerformanceRestrictedStockMember2024-01-012024-06-300001385613glre:ServiceRestrictedStockMember2024-01-012024-06-300001385613glre:PerformanceRestrictedStockMember2024-06-300001385613glre:ServiceRestrictedStockMember2024-06-300001385613us-gaap:RestrictedStockMember2024-01-012024-06-300001385613us-gaap:RestrictedStockMember2023-01-012023-06-300001385613glre:PerformanceRestrictedStockUnitsMember2022-12-310001385613glre:ServiceRestrictedStockUnitsMember2022-12-310001385613glre:PerformanceRestrictedStockUnitsMember2023-01-012023-06-300001385613glre:ServiceRestrictedStockUnitsMember2023-01-012023-06-300001385613glre:PerformanceRestrictedStockUnitsMember2023-06-300001385613glre:ServiceRestrictedStockUnitsMember2023-06-300001385613glre:PerformanceRestrictedStockUnitsMember2023-12-310001385613glre:ServiceRestrictedStockUnitsMember2023-12-310001385613glre:PerformanceRestrictedStockUnitsMember2024-01-012024-06-300001385613glre:ServiceRestrictedStockUnitsMember2024-01-012024-06-300001385613glre:PerformanceRestrictedStockUnitsMember2024-06-300001385613glre:ServiceRestrictedStockUnitsMember2024-06-300001385613glre:PerformanceRestrictedStockUnitsMembersrt:MinimumMember2024-01-012024-06-300001385613srt:MaximumMemberglre:PerformanceRestrictedStockUnitsMember2024-01-012024-06-300001385613srt:ChiefExecutiveOfficerMember2024-01-012024-06-300001385613us-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMember2024-06-300001385613us-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMember2024-01-012024-06-300001385613srt:ChiefExecutiveOfficerMember2024-06-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-06-300001385613us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300001385613us-gaap:EmployeeStockOptionMember2024-04-012024-06-300001385613us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001385613us-gaap:EmployeeStockOptionMember2024-01-012024-06-300001385613us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001385613srt:AffiliatedEntityMemberglre:GreenBricksPartnersIncGRBKMemberglre:SolasglasInvestmentsLPSILPMember2024-06-300001385613srt:AffiliatedEntityMemberglre:SolasglasInvestmentsLPSILPMemberglre:GreenBricksPartnersIncGRBKMember2024-06-300001385613srt:AffiliatedEntityMemberglre:SolasglasInvestmentsLPSILPMemberglre:GreenBricksPartnersIncGRBKMemberus-gaap:SubsequentEventMember2024-07-310001385613srt:BoardOfDirectorsChairmanMemberglre:ServiceAgreementMember2024-01-012024-06-300001385613srt:BoardOfDirectorsChairmanMemberglre:CollateralAssetsInvestementManagementAgreementMember2019-01-012019-01-010001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2024-04-012024-06-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2023-04-012023-06-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2024-01-012024-06-300001385613us-gaap:PropertyAndCasualtyCommercialInsuranceProductLineMember2023-01-012023-06-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2024-04-012024-06-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2023-04-012023-06-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2024-01-012024-06-300001385613glre:MotorVehiclePhysicalDamageProductLineMember2023-01-012023-06-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2024-04-012024-06-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2023-04-012023-06-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2024-01-012024-06-300001385613us-gaap:PropertyAndCasualtyPersonalInsuranceProductLineMember2023-01-012023-06-300001385613us-gaap:PropertyInsuranceProductLineMember2024-04-012024-06-300001385613us-gaap:PropertyInsuranceProductLineMember2023-04-012023-06-300001385613us-gaap:PropertyInsuranceProductLineMember2024-01-012024-06-300001385613us-gaap:PropertyInsuranceProductLineMember2023-01-012023-06-300001385613us-gaap:GeneralLiabilityMember2024-04-012024-06-300001385613us-gaap:GeneralLiabilityMember2023-04-012023-06-300001385613us-gaap:GeneralLiabilityMember2024-01-012024-06-300001385613us-gaap:GeneralLiabilityMember2023-01-012023-06-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2024-04-012024-06-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2023-04-012023-06-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2024-01-012024-06-300001385613glre:MotorVehicleLiabilityCasualtyProductLineMember2023-01-012023-06-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2024-04-012024-06-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2023-04-012023-06-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2024-01-012024-06-300001385613us-gaap:ProfessionalMalpracticeLiabilityMember2023-01-012023-06-300001385613glre:WorkersCompensationInsuranceProductLineMember2024-04-012024-06-300001385613glre:WorkersCompensationInsuranceProductLineMember2023-04-012023-06-300001385613glre:WorkersCompensationInsuranceProductLineMember2024-01-012024-06-300001385613glre:WorkersCompensationInsuranceProductLineMember2023-01-012023-06-300001385613glre:MultilineMember2024-04-012024-06-300001385613glre:MultilineMember2023-04-012023-06-300001385613glre:MultilineMember2024-01-012024-06-300001385613glre:MultilineMember2023-01-012023-06-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2024-04-012024-06-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2023-04-012023-06-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2024-01-012024-06-300001385613glre:LiabilityandCasualtyInsuranceProductLineMember2023-01-012023-06-300001385613us-gaap:HealthInsuranceProductLineMember2024-04-012024-06-300001385613us-gaap:HealthInsuranceProductLineMember2023-04-012023-06-300001385613us-gaap:HealthInsuranceProductLineMember2024-01-012024-06-300001385613us-gaap:HealthInsuranceProductLineMember2023-01-012023-06-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2024-04-012024-06-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2023-04-012023-06-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2024-01-012024-06-300001385613glre:FinancialGuaranteeInsuranceandSuretyProductLineMember2023-01-012023-06-300001385613glre:MarineCasualtyInsuranceMember2024-04-012024-06-300001385613glre:MarineCasualtyInsuranceMember2023-04-012023-06-300001385613glre:MarineCasualtyInsuranceMember2024-01-012024-06-300001385613glre:MarineCasualtyInsuranceMember2023-01-012023-06-300001385613us-gaap:OtherInsuranceProductLineMember2024-04-012024-06-300001385613us-gaap:OtherInsuranceProductLineMember2023-04-012023-06-300001385613us-gaap:OtherInsuranceProductLineMember2024-01-012024-06-300001385613us-gaap:OtherInsuranceProductLineMember2023-01-012023-06-300001385613glre:TotalSpecialtyDomain2024-04-012024-06-300001385613glre:TotalSpecialtyDomain2023-04-012023-06-300001385613glre:TotalSpecialtyDomain2024-01-012024-06-300001385613glre:TotalSpecialtyDomain2023-01-012023-06-300001385613glre:UNITEDSTATESAndCaribbeanMember2024-04-012024-06-300001385613glre:UNITEDSTATESAndCaribbeanMember2023-04-012023-06-300001385613glre:UNITEDSTATESAndCaribbeanMember2024-01-012024-06-300001385613glre:UNITEDSTATESAndCaribbeanMember2023-01-012023-06-300001385613glre:WorldwideMember2024-04-012024-06-300001385613glre:WorldwideMember2023-04-012023-06-300001385613glre:WorldwideMember2024-01-012024-06-300001385613glre:WorldwideMember2023-01-012023-06-300001385613srt:EuropeMember2024-04-012024-06-300001385613srt:EuropeMember2023-04-012023-06-300001385613srt:EuropeMember2024-01-012024-06-300001385613srt:EuropeMember2023-01-012023-06-300001385613srt:AsiaMember2024-04-012024-06-300001385613srt:AsiaMember2023-04-012023-06-300001385613srt:AsiaMember2024-01-012024-06-300001385613srt:AsiaMember2023-01-012023-06-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
__________________________
FORM 10-Q 
__________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2024

or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from     to
Commission file number 001-33493
____________________________________________________________________________________
GREENLIGHT CAPITAL RE, LTD.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________
Cayman Islands N/A
(State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.)
65 Market Street
Suite 1207, Jasmine Court
P.O. Box 31110
Camana Bay
Grand Cayman
Cayman Islands KY1-1205
(Address of principal executive offices) (Zip code)

(205) 291-3440
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Ordinary Shares GLRE Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.: 
Large accelerated filer ☐         Accelerated filer ☒          Non-accelerated filer ☐          Smaller reporting company ☐          Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) 
Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Ordinary Shares, $0.10 par value 35,321,144
(Class) Outstanding at August 2, 2024



GREENLIGHT CAPITAL RE, LTD.
 
TABLE OF CONTENTS
 
    Page
  Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023
  Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023 (unaudited)
  Condensed Consolidated Statements of Changes in Shareholders' Equity for the three and six months ended June 30, 2024 and 2023 (unaudited)
  Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023 (unaudited)
  Notes to the Condensed Consolidated Financial Statements (unaudited)


 
2


PART I — FINANCIAL INFORMATION

NOTE OF FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (herein referred as “Form 10-Q”) of Greenlight Capital Re, Ltd. (“Greenlight Capital Re,” “Company,” “us,” “we,” or “our”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical facts included in this report, including statements regarding estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements”. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the United States (“U.S.”) federal securities laws established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are not historical facts, and are based on current expectations, estimates and projections, and various assumptions, many of which, are inherently uncertain and beyond management’s control.

Forward-looking statements contained in this Form 10-Q may include, but are not limited to, information regarding our estimates for catastrophes and weather-related losses (herein referred as “CAT losses”), measurements of potential losses in the fair market value of our investments, our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, the outcome of our strategic initiatives, our expectations regarding pricing, and other market and economic conditions including inflation, our growth prospects, and valuations of the potential impact of movements in interest rates, equity securities’ prices, and foreign currency exchange rates.

Forward-looking statements only reflect our expectations and are not guarantees of performance. These statements involve risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual events or results to differ materially from those indicated in such statements. We believe that these factors include, but are not limited to:

•a downgrade or withdrawal of our A.M. Best ratings;
•any suspension or revocation of any of our licenses;
•losses from catastrophes and other major events;
•the loss of significant brokers; and
•those described under “Item 1A, Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended December 31,2023, as filed with the SEC on March 5, 2024 (“2023 Form 10-K”), which is accessible on the SEC’s website at www.sec.gov.

We undertake no obligation to publicly update or revise any forward-looking statements, whether due to new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only to the dates they were made.

We intend to communicate certain events that we believe may have a material adverse impact on our operations or financial position, including property and casualty catastrophic events and material losses in our investment portfolio, in a timely manner through a public announcement. Other than as required by the Exchange Act, we do not intend to make public announcements regarding underwriting or investment events that we do not believe, based on management’s estimates and current information, will have a material adverse impact on our operations or financial position.















3


Item 1. FINANCIAL STATEMENTS 
GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS

June 30, 2024 (unaudited) and December 31, 2023
(expressed in thousands of U.S. dollars, except per share and share amounts)
  June 30, 2024 December 31, 2023
Assets    
Investments  
Investment in related party investment fund, at fair value $ 351,468  $ 258,890 
Other investments 73,159  73,293 
Total investments 424,627  332,183 
Cash and cash equivalents 52,240  51,082 
Restricted cash and cash equivalents 561,930  604,648 
Reinsurance balances receivable (net of allowance for expected credit losses of 2024: $865 and 2023: $854)
686,743  619,401 
Loss and loss adjustment expenses recoverable (net of allowance for expected credit losses of 2024: $701 and 2023: $487)
58,647  25,687 
Deferred acquisition costs 83,305  79,956 
Unearned premiums ceded 28,184  17,261 
Other assets 4,272  5,089 
Total assets $ 1,899,948  $ 1,735,307 
Liabilities and equity  
Liabilities  
Loss and loss adjustment expense reserves $ 752,757  $ 661,554 
Unearned premium reserves 349,015  306,310 
Reinsurance balances payable 76,253  68,983 
Funds withheld 18,266  17,289 
Other liabilities 8,042  11,795 
Debt 61,595  73,281 
Total liabilities 1,265,928  1,139,212 
Commitments and Contingencies (Note 15)
Shareholders' equity  
Preferred share capital (par value $0.10; none issued)
—  — 
Ordinary share capital (par value $0.10; issued and outstanding, 35,321,144) (2023: par value $0.10; issued and outstanding, 35,336,732)
3,532  3,534 
Additional paid-in capital 487,462  484,532 
Retained earnings 143,026  108,029 
Total shareholders' equity 634,020  596,095 
Total liabilities and equity $ 1,899,948  $ 1,735,307 
 


  The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.



GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED) 
For the three and six months ended June 30, 2024 and 2023
(expressed in thousands of U.S. dollars, except per share and share amounts)
Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Revenues  
Gross premiums written $ 168,975  $ 154,943  $ 386,233  $ 341,398 
Gross premiums ceded (14,832) (9,739) (38,013) (20,951)
Net premiums written 154,143  145,204  348,220  320,447 
Change in net unearned premium reserves 4,255  (5,261) (28,286) (37,855)
Net premiums earned 158,398  139,943  319,934  282,592 
Income (loss) from investment in related party investment fund (net of related party expenses - Note 3) 4,330  32,782  22,578  29,644 
Net investment income 8,224  9,369  16,367  17,747 
Foreign exchange gains (losses) (932) 4,729  (2,581) 9,660 
Other income, net 4,843  2,866  9,878  5,032 
Total revenues 174,863  189,689  366,176  344,675 
Expenses
Net loss and loss adjustment expenses incurred 102,033  90,504  211,359  187,229 
Acquisition costs 50,454  38,293  92,064  79,769 
General and administrative expenses 10,517  10,025  21,231  19,961 
Deposit interest expense 1,886  235  2,762  367 
Interest expense 1,560  744  2,809  1,520 
Total expenses 166,450  139,801  330,225  288,846 
Income before income tax 8,413  49,888  35,951  55,829 
Income tax expense (435) (28) (954) (82)
Net income $ 7,978  $ 49,860  $ 34,997  $ 55,747 
Earnings (loss) per share ("EPS"):
  Basic $ 0.23  $ 1.46  $ 1.02  $ 1.64 
  Diluted $ 0.23  $ 1.32  $ 1.01  $ 1.49 
Weighted average number of ordinary shares used in the determination of EPS:
  Basic 34,238,863  34,070,818  34,255,454  34,065,066 
  Diluted 34,699,182  38,267,137  34,679,325  38,322,921 
 










 
The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements.  
5


GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(UNAUDITED)
 For the three and six months ended June 30, 2024 and 2023
(expressed in thousands of U.S. dollars)

Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Ordinary share capital
Balance - beginning of period $ 3,532  $ 3,526  $ 3,534  $ 3,482 
Issue of ordinary shares, net of forfeitures —  (2) 45 
Balance - end of period 3,532  3,527  3,532  3,527 
Additional paid-in capital
Balance - beginning of period 485,878  479,429  484,532  478,439 
Share-based compensation expense 1,584  1,219  2,930  2,209 
Balance - end of period 487,462  480,648  487,462  480,648 
Retained earnings
Balance - beginning of period 135,048  27,086  108,029  21,199 
Net income 7,978  49,860  34,997  55,747 
Balance - end of period 143,026  76,946  143,026  76,946 
Total shareholders' equity $ 634,020  $ 561,121  $ 634,020  $ 561,121 






















The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 

6


GREENLIGHT CAPITAL RE, LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
For the six months ended June 30, 2024 and 2023
(expressed in thousands of U.S. dollars) 
Six months ended June 30
  2024 2023
Cash flows from operating activities  
Net income $ 34,997  $ 55,747 
Adjustments to reconcile net income or loss to net cash provided by (used in) operating activities:
   Income from investments in related party investment fund (22,578) (29,644)
   Net realized gain on repurchases of convertible senior notes payable —  (265)
   Net realized and unrealized losses (gains) on other investments 324  (256)
   Net realized and unrealized losses (gains) on derivatives (565) — 
   Current expected credit losses (gains) recognized on reinsurance assets 225  500 
   Share-based compensation expense 2,928  2,254 
   Accretion of debt offering costs and change in interest accruals 190  (59)
   Net change in:
     Reinsurance balances receivable (67,353) (111,672)
     Loss and loss adjustment expenses recoverable (33,174) (8,316)
     Deferred acquisition costs (3,349) (626)
     Unearned premiums ceded (10,923) (1,074)
     Loss and loss adjustment expense reserves 91,203  65,633 
     Unearned premium reserves 42,705  30,234 
     Reinsurance balances payable 7,270  4,399 
     Funds withheld 977  (6,302)
     Other items, net (2,208) 13 
Net cash provided by (used in) operating activities 40,669  566 
Cash flows from investing activities
Proceeds from redemptions of investment in Solasglas —  37,997 
Contributions to investment in Solasglas (70,000) (47,001)
Purchases of other investments (414) (4,045)
Proceeds on disposal of other investments 168  6,000 
Net cash provided by (used in) investing activities (70,246) (7,049)
Cash flows from financing activities
Repayment of term loans (11,876) — 
Repurchases of convertible senior notes payable —  (17,085)
Net cash used in financing activities (11,876) (17,085)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash (107) 351 
Decrease in cash, cash equivalents and restricted cash (41,560) (23,217)
Cash, cash equivalents and restricted cash at beginning of the period 655,730  706,548 
Cash, cash equivalents and restricted cash at end of the period $ 614,170  $ 683,331 
Supplementary information  
Interest paid in cash $ 3,315  $ 1,578 
Income tax paid (refund received) in cash
153  21 

The accompanying Notes to the Condensed Consolidated Financial Statements are an
integral part of the Condensed Consolidated Financial Statements. 
7


GREENLIGHT CAPITAL RE, LTD.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
June 30, 2024
  
1. ORGANIZATION AND BASIS OF PRESENTATION

Organization
 
Greenlight Capital Re, Ltd. (“GLRE” and, together with its wholly-owned subsidiaries, the “Company”) was incorporated as an exempted company under the Companies Law of the Cayman Islands on July 13, 2004. The Company is a global specialty property and casualty reinsurer headquartered in the Cayman Islands. The ordinary shares of GLRE are listed on Nasdaq Global Select Market under the symbol “GLRE.”

Basis of Presentation

These unaudited condensed consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the U.S. Securities and Exchange Commission’s (“SEC”) instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s 2023 Form 10-K. The financial statements include the accounts of GLRE and the consolidated financial statements of its wholly-owned subsidiaries and all significant intercompany transactions and balances have been eliminated on consolidation.

In the opinion of management, these financial statements reflect all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company’s financial position and results of operations as at the end of and for the periods presented. The results of operations for any interim period are not necessarily indicative of the results for a full year.

Tabular dollars are in thousands, with the exception of per share amounts or otherwise noted. All amounts are reported in U.S. dollars.

Reclassifications

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current financial statements. The Company has reported separately the foreign exchange gains (losses) from “Other income” in the condensed consolidated statements of operations. This resulted in no change to the previously reported total revenues or net income. The Company has also included the foreign exchange gains (losses) as part of the net change in working capital in the condensed consolidated statements of cash flows. Further, the Company combined “Other assets, excluding depreciation” and “Other liabilities” and presented the sum as “Other items, net” in the condensed consolidated statements of cash flows. These changes in presentation in the condensed consolidated statements of cash flows have resulted in no change to the previously reported net cash provided by (used in) operating activities.

2. SIGNIFICANT ACCOUNTING POLICIES
 
There were no material changes to the Company’s significant accounting policies subsequent to its 2023 Form 10-K.

Recently Issued Accounting Standards Not Yet Adopted

On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting - Improvements to Reportable Segment Disclosures. The new ASU requires incremental disclosures related to a public entity’s reportable segments but does not change the definition of a segment, the method for determining segments, or the criteria for aggregating operating segments into reportable segments. This new guidance is effective for the Company’s 2024 year-end financial statements, and should be adopted retrospectively unless impracticable. Early adoption is permitted.

8


On December 14, 2023, FASB issued ASU 2023-09, Income Taxes Topic (740) - Improvements to Income Tax Disclosures. The new ASU provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. Early adoption is permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. This ASU is effective for the Company’s 2024 year-end financial statements.

As the above ASUs relate solely to financial statement disclosures, the adoption of these ASUs will not impact the Company’s financial condition, results of operations, or cash flows.

3. INVESTMENT IN RELATED PARTY INVESTMENT FUND

For the three and six months ended June 30, 2024, there was no change to the Company’s agreement with Solasglas Investments, LP (“Solasglas”). Effective August 1, 2024, the parties amended the agreement to revise the Investment Cap from 60% to 70% (as defined in Note 3 of the 2023 Form 10-K).

The Company’s maximum exposure to loss relating to Solasglas is limited to GLRE's share of Partners’ capital in Solasglas. At June 30, 2024, GLRE’s share of Partners’ capital in Solasglas was $351.5 million (December 31, 2023: $258.9 million), representing 76.3% (December 31, 2023: 72.7%) of Solasglas’ total net assets. DME II held the remaining 23.7% (December 31, 2023: 27.3%) of Solasglas’ total net assets.

The Company’s share of the net increase in Partner’s capital for the three and six months ended June 30, 2024 was $4.3 million and $22.6 million, respectively, (three and six months ended June 30, 2023: $32.8 million and $29.6 million, respectively), as shown in the caption “Income (loss) from investment in related party investment fund” in the Company’s condensed consolidated statements of operations.

The summarized financial statements of Solasglas are presented below.

Summarized Statements of Financial Condition of Solasglas Investments, LP
June 30, 2024 December 31, 2023
Assets
Investments, at fair value $ 401,510  $ 453,358 
Derivative contracts, at fair value 11,244  11,167 
Due from brokers 169,898  121,754 
Cash and cash equivalents 53,460  — 
Interest and dividends receivable 195  1,143 
Total assets 636,307  587,422 
Liabilities and partners’ capital
Liabilities
Investments sold short, at fair value (162,984) (197,571)
Derivative contracts, at fair value (11,147) (12,917)
Capital withdrawals payable —  (1,000)
Due to brokers —  (17,398)
Interest and dividends payable (1,404) (2,315)
Accrued expenses and other liabilities (164) (247)
Total liabilities (175,699) (231,448)
Partners' capital $ 460,608  $ 355,974 
GLRE’s share of Partners' capital
$ 351,468  $ 258,890 

9


Summarized Statements of Operations of Solasglas Investments, LP
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Investment income
Dividend income (net of withholding taxes) $ 941  $ 724  $ 1,772  $ 1,351 
Interest income 2,148  2,076  6,500  3,892 
Total Investment income 3,089  2,800  8,272  5,243 
Expenses
Management fee (1,408) (1,163) (2,731) (2,231)
Interest (736) (1,579) (2,070) (3,007)
Dividends (731) (793) (1,435) (1,212)
Professional fees and other (335) (607) (659) (889)
Total expenses (3,210) (4,142) (6,895) (7,339)
Net investment income (loss) (121) (1,342) 1,377  (2,096)
Realized and change in unrealized gains (losses)
Net realized gain (loss) 20,085  (845) 63,030  (2,605)
Net change in unrealized appreciation (depreciation) (13,138) 54,825  (29,383) 53,792 
Net gain (loss) on investment transactions 6,947  53,980  33,647  51,187 
Net increase (decrease) in Partners' capital (1)
$ 6,826  $ 52,638  $ 35,024  $ 49,091 
GLRE’s share of the increase (decrease) in Partners' capital
$ 4,330  $ 32,782  $ 22,578  $ 29,644 

(1) The net increase in Partners’ capital is net of management fees and performance allocation presented below:

Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Management fees $ 1,408  $ 1,163  $ 2,731  $ 2,231 
Performance allocation 481  $ 3,294  2,509  3,294 
Total $ 1,889  $ 4,457  $ 5,240  $ 5,525 


4. OTHER INVESTMENTS  
 
At June 30, 2024, the breakdown of the Company’s other investments was as follows:
Cost Unrealized
gains
Unrealized
losses
Accrued interest Fair value / carrying value
Private investments and unlisted equities $ 27,170  $ 49,902  $ (5,206) $ —  $ 71,866 
Debt and convertible debt securities 2,713  —  (1,510) 90  1,293 
Total other investments $ 29,883  $ 49,902  $ (6,716) $ 90  $ 73,159 

10



At December 31, 2023, the breakdown of the Company’s other investments was as follows:

Cost Unrealized
gains
Unrealized
losses
Accrued interest Fair value / carrying value
Private investments and unlisted equities $ 28,470  $ 49,424  $ (6,737) $ —  $ 71,157 
Debt and convertible debt securities 2,499  —  (499) 136  2,136 
Total other investments $ 30,969  $ 49,424  $ (7,236) $ 136  $ 73,293 

The following table presents the carrying values of the private investments and unlisted equity securities carried under the measurement alternative at June 30, 2024 and 2023, and the related adjustments recorded during the periods then ended.
Six months ended June 30
2024 2023
Carrying value (1)
$ 71,866  $ 65,904 
Upward carrying value changes (2)
$ 501  $ 506 
Downward carrying value changes and impairment (3)
$ (114) $ (250)

(1) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes.
(2) The cumulative upward carrying value changes from inception to June 30, 2024, totaled $50.9 million.
(3) The cumulative downward carrying value changes and impairments from inception to June 30, 2024, totaled $2.8 million.


Net investment income

The following table summarizes the change in unrealized gains (losses) and the realized gains (losses) for the Company’s other investments, which are included in “Net investment income” in the condensed consolidated statements of operations (see Note 13):
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Gross realized gains $ —  $ —  $ —  $ — 
Gross realized losses —  —  (1,332) (800)
Net realized gains (losses) $ —  $ —  $ (1,332) $ (800)
Change in unrealized gains 89  506  1,008  1,056 
Net realized and unrealized gains (losses) on other investments $ 89  $ 506  $ (324) $ 256 

During the six months ended June 30, 2024, the Company collected $0.2 million of liquidation proceeds relating to a private investment which was previously fully impaired, resulting in a gross realized loss of $1.3 million offset by a corresponding reduction in unrealized losses of $1.5 million.

During the three and six months ended June 30, 2023, the Company realized a loss of $nil and $0.8 million, respectively, and a corresponding reversal of unrealized loss relating to an investment which was previously fully impaired at December 31, 2022, resulting in no impact to the Company’s net income (loss).


11



5. RESTRICTED CASH AND CASH EQUIVALENTS

The following table shows the breakdown of the Company’s restricted cash and cash equivalents, along with a reconciliation of the total cash, cash equivalents, and restricted cash reported in the condensed consolidated statements of cash flows:
  June 30, 2024 December 31, 2023
Restricted cash and cash equivalents:
  Cash securing trust accounts $ 274,275  $ 300,152 
  Cash securing letters of credit issued 274,048  291,456 
  Cash securing Loan Facility 10,000  10,000 
  Other 3,607  3,040 
Total restricted cash and cash equivalents 561,930  604,648 
Cash and cash equivalents 52,240  51,082 
Total cash, cash equivalents, and restricted cash $ 614,170  $ 655,730 

Where the Company operates as a non-admitted carrier in certain foreign jurisdictions, regulatory trust accounts and letters of credit are issued to cedents. Additionally, the Company has provided cash collateral for the Loan Facility (see Note 9).


6. FAIR VALUE MEASUREMENTS

Assets measured at fair value on a nonrecurring basis

At June 30, 2024 and December 31, 2023, the Company held $61.8 million and $61.3 million, respectively, of private investments and unlisted equities measured at fair value on a nonrecurring basis. At June 30, 2024, the Company held $10.0 million (2023: $9.9 million) of private investments and unlisted equities measured at cost. The Company classifies these investments as Level 3 within the fair value hierarchy.

The following table summarizes the periods between the most recent fair value measurement dates and June 30, 2024, for the private and unlisted equities measured at fair value on a nonrecurring basis:

Less than 6 months 6 to 12 months Over 1 year Total
Fair values measured on a nonrecurring basis $ 1,423  $ 26,338  $ 34,086  $ 61,847 

Assets measured at fair value on a recurring basis

Derivative financial instruments

The Company uses interest rate swaps in connection with its risk management activities to hedge 50% of the interest rate risk relating to the outstanding Term Loans (see Note 9). The interest rate swaps are carried at fair value and are determined using a market approach valuation technique based on significant observable market inputs from third-party pricing vendors. Accordingly, the interest rates swaps are classified as Level 2 within the fair value hierarchy. These derivative instruments are not designated as accounting hedges under U.S. GAAP.

For the three and six months ended June 30, 2024, the Company recognized a reduction in unrealized loss of $0.1 million and $0.6 million, respectively, for the above derivatives to a nominal value at June 30, 2024, which is included in other liabilities in the condensed consolidated balance sheets, in interest expense in the condensed consolidated statements of operations, and in “net change in unrealized gains and losses on investments and derivatives” in the condensed consolidated statements of cash flows. There were no derivative financial instruments for the three and six months ended June 30, 2023.




12



Financial Instruments Disclosed, But Not Carried, at Fair Value

At June 30, 2024, the carrying value of debt and convertible debt securities within “Other Investments” (see Note 4) and the Term Loans approximates their fair values. The Company classifies these financial instruments as Level 2 within the fair value hierarchy.


7. LOSS AND LOSS ADJUSTMENT EXPENSE RESERVES

The Company’s loss and loss adjustment expense (“LAE”) reserves were composed of the following:
June 30, 2024 December 31, 2023
Case reserves $ 210,802  $ 189,050 
IBNR 541,955  472,504 
Total $ 752,757  $ 661,554 

Reserve Roll-forward

The following provides a summary of changes in outstanding loss and LAE reserves for all lines of business:
Consolidated Six months ended June 30
2024 2023
Gross balance at January 1 $ 661,554  $ 555,468 
Less: Losses recoverable (25,687) (13,239)
Net balance at January 1 635,867  542,229 
Incurred losses related to:    
Current year 206,647  173,428 
Prior years 4,712  13,801 
Total incurred 211,359  187,229 
Paid losses related to:    
Current year (20,677) (22,428)
Prior years (129,716) (114,056)
Total paid (150,393) (136,484)
Foreign currency revaluation (2,723) 6,572 
Net balance at June 30 694,110  599,546 
Add: Losses recoverable (see Note 8)
58,647  21,555 
Gross balance at June 30 $ 752,757  $ 621,101 

Estimates for Significant Catastrophe Events

At June 30, 2024, the Company’s net reserves for losses and loss expenses include estimated amounts for several catastrophe and weather-related events (“CAT loss”). The magnitude and volume of losses arising from these events is inherently uncertain and, consequently, actual losses for these events may ultimately differ, potentially materially, from current estimates.

During the six months ended June 30, 2024, the Company recognized total CAT loss, net of reinsurance, of $35.2 million. Current year CAT loss events were $25.7 million, driven mainly by the Baltimore bridge collapse, the U.S. tornados (including severe convective storms), satellite failures, and a Mexican state-owned oil platform fire. Additionally, the Company incurred $9.4 million of net adverse prior year CAT loss development relating primarily to severe weather affecting U.S. homeowners’ property coverage (2021-2023 underwriting years).

During the six months ended June 30, 2023, the Company recognized total CAT loss, net of reinsurance, of $19.6 million. Current year CAT loss events were $16.4 million, driven mainly by the Turkey earthquake, New Zealand Cyclone Gabrielle and the U.S. tornados, coupled with $3.2 million net adverse prior year CAT loss development mainly relating to the 2022 Winter Storm Elliott.
13




Prior Year Reserve Development

During the six months ended June 30, 2024, the Company experienced $4.7 million in net adverse development on prior year loss and LAE reserves. This was composed of $19.5 million of reserve strengthening predominantly for the above prior year CAT loss events, coupled with additional losses reported on general liability contracts (mostly 2014-2017 underwriting years) and legacy quota share workers’ compensation treaties (mostly 2017-2021 underwriting years) due to current economic and social inflation trends. The reserve increases were partially offset by $14.8 million favorable loss development predominantly from mortgage contracts (various underwriting years), multi-line commercial treaties (mostly 2020 underwriting year), Funds at Lloyd’s (“FAL”) (2023 underwriting year), and other specialty business (mostly 2020-2022 underwriting years).

During the six months ended June 30, 2023, the Company experienced $13.8 million in net adverse development on prior year loss and LAE reserves. This was comprised of $21.5 million of reserve strengthening predominantly on casualty contracts (mostly 2018, 2019 and 2021 underwriting years) and property contracts (mostly 2020 and 2021 underwriting years) due to current economic and social inflation trends, coupled with adverse CAT loss development on U.S. homeowners’ property business relating to Winter Storm Elliott (2022 underwriting year). This was partially offset by $7.7 million better than expected loss emergence predominantly from other property catastrophe events (mostly 2019, 2021 and 2022 underwriting years).


8. RETROCESSION

The following table provides a breakdown of ceded reinsurance:
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Gross ceded premiums $ 14,832  $ 9,739  $ 38,013  $ 20,951 
Earned ceded premiums $ 11,849  $ 11,296  $ 27,091  $ 19,877 
Loss and loss adjustment expenses ceded $ 14,773  $ 9,537  $ 37,849  $ 15,708 

Retrocession contracts do not relieve the Company from its obligations to its cedents. Failure of retrocessionaires to honor their obligations could result in losses to the Company. The following table shows a breakdown of losses recoverable on a gross and net of collateral basis:

June 30, 2024 December 31, 2023
 
Gross
Net of Collateral(1)
Gross
Net of Collateral(1)
A- or better by A.M. Best
$ 33,288  $ 33,288  $ 8,767  $ 8,767 
Not rated
26,059  8,816  17,407  2,432 
Total before provision
59,347  $ 42,104  $ 26,174  $ 11,199 
Provision for credit losses
(700) (487)
Total loss and loss adjustment expenses recoverable, net
$ 58,647  $ 25,687 
(1) Collateral is in the form of cash, letters of credit, funds withheld, and/or cash collateral held in trust accounts. This excludes any excess collateral in order to disclose the aggregate net exposure for each retrocessionaire.
At June 30, 2024, we had 3 reinsurers (December 31, 2023: 3) that accounted for 10% or more of the total loss and loss adjustment expenses recoverable, net, for an aggregate gross amount of $42.3 million (December 31, 2023: $20.4 million).

14


9. DEBT AND CREDIT FACILITIES

Debt Obligations

The following table summarizes the Company’s outstanding debt obligations.
June 30, 2024 December 31, 2023
Term loans
$ 62,188  $ 74,062 
Accrued interest payable 38  — 
Less: deferred financing costs
(631) (781)
Total debt $ 61,595  $ 73,281 

During the six months ended June 30, 2024, the Company partially repaid $11.9 million of the outstanding Term loans.

Credit Facilities

At June 30, 2024, the Company had the following letter of credit (“LOC”) facilities:
Capacity
LOCs issued
Termination Date
Citibank Europe plc ("Citi LOC")1
$ 289,000  $ 231,665  August 20, 2024
CIBC Bank USA ("CIBC LOC")
200,000  42,338  December 21, 2024
  $ 489,000  $ 274,003 
1) Includes $14 million of uncommitted capacity.
The above LOCs issued are cash collateralized (see Note 5). The LOC facilities are subject to various customary affirmative, negative and financial covenants. At June 30, 2024, the Company was in compliance with all LOC facilities covenants.
On April 12, 2024, the Company received written notice from Citibank Europe plc (“Citi”) of its decision to terminate the $275 million committed capacity under the Citi LOC agreement, with an effective date of August 20, 2024. However, Citi informed the Company that it intends to continue providing the Citi LOC on an uncommitted basis for the foreseeable future following the termination date.

10. SHARE CAPITAL

Ordinary Shares

The following table is a summary of changes in ordinary shares issued and outstanding for the six months ended June 30:
  2024 2023
Ordinary Class A Class B
Balance – beginning of period 35,336,732  28,569,346  6,254,715 
Issue of shares, net of forfeitures (15,588) 447,952  — 
Balance – end of period 35,321,144  29,017,298  6,254,715 

The Company’s authorized share capital is 125,000,000 ordinary shares, par value of $0.10 per share.

On July 25, 2023, at the Company’s Annual General Meeting the shareholders approved the re-designation of Class B ordinary shares as Class A ordinary shares, and then reclassified Class A ordinary shares as “ordinary shares”, resulting in the elimination of the dual-class share structure.

At June 30, 2024, the Company has an effective Form S-3 registration statement on file with the SEC for an aggregate principal amount of $200.0 million in securities.

Share Repurchase Plan

On May 3, 2024, the Board of Directors re-approved the share repurchase plan, until June 30, 2025, authorizing the Company to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans.
15


Any shares repurchased are canceled immediately upon repurchase. For the six months ended June 30, 2024 and 2023, there was no repurchase of ordinary shares.

Preferred Shares

The Company’s authorized share capital also consists of 50,000,000 preference shares with a par value of $0.10 each. At June 30, 2024, the Company has no issued and outstanding preferred shares.

11. SHARE-BASED COMPENSATION
 
Refer to Note 11 of the Company’s audited consolidated financial statements of its 2023 Form 10-K for a summary of the Company’s 2023 Incentive Plan, including the definition of performance-based and service-based stock awards.

Employee and Director Restricted Shares

The following table summarizes the activity for unvested outstanding restricted share awards (“RSs”) during the six months ended June 30, 2024 and 2023:

Performance Restricted Shares Service Restricted Shares
  Number of
non-vested
restricted
 shares
Weighted
 average
grant date
fair value
Number of
non-vested
restricted
 shares
Weighted
 average
grant date
fair value
Balance at December 31, 2022 794,362  $ 7.62  832,896  $ 7.76 
Granted 357,766  9.85  177,563  9.84 
Vested —  —  (256,243) 6.75 
Forfeited (109,105) 9.37  (55,967) 8.43 
Balance at June 30, 2023 1,043,023  $ 8.20  698,249  $ 8.60 
Balance at December 31, 2023 1,042,688  $ 9.94  419,604  $ 9.18 
Granted —  —  —  — 
Vested —  —  (217,522) 8.78 
Forfeited (89,945) 10.84  —  — 
Balance at June 30, 2024 952,743  $ 9.86  202,082  $ 9.61 

At June 30, 2024, 2,914,198 (December 31, 2023: 3,296,771) ordinary shares remained available for future issuance under the Company’s 2023 Incentive Plan.

There was no grant of RSs during the six months ended June 30, 2024 (2023: 535,329). For the six months ended June 30, 2024, the total fair value of Service RSs vested was $1.9 million (2023: $1.7 million).

16


Employee Restricted Stock Units

The following table summarizes the activity for unvested outstanding restricted stock units (“RSUs”) during the six months ended June 30, 2024 and 2023:
Performance RSUs
Service RSUs
  Number of
non-vested
RSUs
Weighted
 average
grant date
fair value
Number of
non-vested
RSUs
Weighted
 average
grant date
fair value
Balance at December 31, 2022 105,008  $ 6.82  172,952  $ 7.58 
Granted 71,121  9.85  42,811  9.85 
Vested —  —  (77,695) 6.74 
Forfeited —  —  (1,788) 7.82 
Balance at June 30, 2023 176,129  $ 8.04  136,280  $ 8.76 
Balance at December 31, 2023 154,445  $ 8.03  110,425  $ 8.78 
Granted 258,148  11.85  124,425  11.85 
Vested —  —  (74,357) 8.84 
Forfeited —  —  —  — 
Balance at June 30, 2024 412,593  $ 10.42  160,493  $ 11.14 

For the awards granted during the six months ended June 30, 2024, the Service RSUs vest evenly over three years on January 1, subject to the grantee’s continued service with the Company. If performance goals are achieved, the Performance RSUs will cliff vest at the end of a three-year performance period within a range of 50% and 200% of the awarded Performance RSUs, with a target of 100%.

For the six months ended June 30, 2024, the total fair value of Service RSUs vested was $0.7 million (2023: $0.5 million).

Employee and Director Stock Options

During the six months ended June 30, 2024, 250,000 ordinary share purchase options were granted to the Company’s CEO, pursuant to his employment contract. These options vest 50,000 annually and expire in 10 years from the grant date. The grant date fair value of these options was $4.31 per share, based on the Black-Scholes option pricing model. The following inputs were used in this pricing model:
Expected volatility
36.4  %
Expected term (in years)
5
Expected dividend yield
—  %
Risk-free interest rate
3.9  %
Stock price at grant date
$ 11.20 

Stock Compensation Expense

For the six months ended June 30, 2024 and 2023, the Company recorded $2.9 million and $2.3 million of total stock compensation expense (net of forfeitures), respectively. The stock compensation expense is included in “General and administrative expenses” in the condensed consolidated statements of operations. Forfeiture recoveries were immaterial for both periods.





17





12. EARNINGS PER SHARE

The following table reconciles net income and weighted average shares used in computing basic and diluted EPS for the three and six months ended June 30, 2024 and 2023:
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Numerator for EPS
Net income - basic $ 7,978  $ 49,860  $ 34,997  $ 55,747 
Add: interest on convertible notes —  744  —  1,520 
Less: gain on repurchase of convertible notes
—  —  —  (265)
Net income - diluted
$ 7,978  $ 50,604  $ 34,997  $ 57,002 
Denominator for EPS
Weighted average shares outstanding - basic 34,238,863  34,070,818  34,255,454  34,065,066 
Effect of dilutive employee and director share-based awards 460,319  580,494  423,871  534,958 
Shares potentially issuable in connection with convertible notes —  3,615,825  —  3,722,897 
Weighted average shares outstanding - diluted 34,699,182  38,267,137  34,679,325  38,322,921 
Anti-dilutive stock options outstanding 902,140  690,337  902,140  690,337 
EPS:
Basic $ 0.23  $ 1.46  $ 1.02  $ 1.64 
Diluted $ 0.23  $ 1.32  $ 1.01  $ 1.49 

13. NET INVESTMENT INCOME

The following table provides a breakdown of net investment income:
Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Interest and dividend income, net of withholding taxes and other expenses $ 8,135  $ 8,863  $ 16,691  $ 17,491 
Net realized and unrealized gains on other investments (see Note 4) 89  506  (324) 256 
Net investment-related income 8,224  9,369  16,367  17,747 
Share of Solasglas' net income (see Note 3) 4,330  32,782  22,578  29,644 
Total investment income $ 12,554  $ 42,151  $ 38,945  $ 47,391 


14. RELATED PARTY TRANSACTIONS 

Investment Advisory Agreement
 
There has been no change to the Company’s agreement with Solasglas as described in its 2023 Form 10-K. Refer to Note 3 for a breakdown of management fees and performance fees for the six months ended June 30, 2024 and 2023.

18


Green Brick Partners, Inc.

David Einhorn also serves as the Chairman of the Board of Directors of Green Brick Partners, Inc. (“GRBK”), a publicly-traded company. At June 30, 2024, Solasglas, along with certain affiliates of DME Advisors, collectively owned 25.2% of the issued and outstanding common shares of GRBK. Under applicable securities laws, DME Advisors may sometimes be limited in its ability to trade GRBK shares held in Solasglas. At June 30, 2024, Solasglas held 1.8 million shares of GRBK. Subsequent to June 30, 2024, Solasglas reduced its exposure to GRBK and as of July 31, 2024 held 1.3 million shares of GRBK.

Service Agreement
 
The Company has entered into a service agreement with DME Advisors, pursuant to which DME Advisors provides certain investor relations services to the Company for compensation of five thousand dollars per month (plus expenses). The agreement automatically renews annually until terminated by either the Company or DME Advisors for any reason with 30 days prior written notice to the other party. 

Collateral Assets Investment Management Agreement

Effective January 1, 2019, the Company (and its subsidiaries) entered into a collateral assets investment management agreement (the “CMA”) with DME Advisors, pursuant to which DME Advisors manages certain assets of the Company that are not subject to the Solasglas LPA and are held by the Company to provide collateral required by the cedents in the form of trust accounts and letters of credit. In accordance with the CMA, DME Advisors receives no fees and is required to comply with the collateral investment guidelines. The CMA can be terminated by any of the parties upon 30 days’ prior written notice to the other parties.


15. COMMITMENTS AND CONTINGENCIES 
 
a) Concentration of Credit Risk

Cash and cash equivalents

The Company monitors its concentration of credit risk with financial institutions and limits acceptable counterparties based on current rating, outlook and other relevant factors.

Investments

The Company’s credit risk exposure to private debt and convertible debt securities within its “Other investments” are immaterial (see Note 4).
Reinsurance balances receivable, net

The following table shows the breakdown of reinsurance balances receivable:

19


June 30, 2024 December 31, 2023
Amount
%
Amount
%
Premiums receivable
$ 260,801  38.0  % $ 186,940  30.2  %
Funds withheld:
  Funds held by cedants
48,790  7.1  % 50,075  8.1  %
  Premiums held by Lloyds' syndicates
264,685  38.5  % 264,278  42.7  %
  Funds at Lloyd’s
110,624  16.1  % 115,772  18.6  %
Profit commission receivable
2,708  0.4  % 2,302  0.4  %
Deposit assets
—  —  % 888  0.1  %
Total before provision
687,608  100.1  % 620,255  100.1  %
Provision for expected credit losses
(865) (0.1) % (854) (0.1) %
Reinsurance balances receivable, net
$ 686,743  100.0  % $ 619,401  100.0  %

The Company has posted deposits at Lloyd’s to support underwriting capacity for certain syndicates, including Syndicate 3456. Lloyd’s has a credit rating of “A” (Excellent) from A.M. Best.

Premiums receivable includes a significant portion of estimated premiums not yet due. Brokers and other intermediaries are responsible for collecting premiums from customers on the Company’s behalf. The Company monitors its concentration of credit risks from brokers. The diversity in the Company’s client base limits credit risk associated with premiums receivable and funds (premiums) held by cedents. Further, under the reinsurance contracts the Company has contractual rights to offset premium balances receivable and funds held by cedants against corresponding payments for losses and loss expenses.

Loss and loss adjustment expenses recoverable, net

The Company regularly evaluates its net credit exposure to the retrocessionaires and their abilities to honor their respective obligations. See Note 8 for analysis of concentration of credit risk relating to retrocessionaires.

b) Lease Obligations

There was no material change to the Company’s operating lease agreements subsequent to its 2023 Form 10-K.

c) Litigation

From time to time, in the ordinary course of business, the Company may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation. The outcomes of these procedures determine the rights and obligations under the Company’s reinsurance contracts and other contractual agreements. In some disputes, the Company may seek to enforce its rights under an agreement or collect funds owed. In other matters, the Company may resist attempts by others to collect funds or enforce alleged rights. While the Company cannot predict the outcome of legal disputes with certainty, the Company does not believe that any existing dispute, when finally resolved, will have a material adverse effect on the Company’s business, financial condition, or operating results.
20


16. SEGMENT REPORTING
 
The Company has one operating segment: Property & Casualty Reinsurance.

The following tables provide a breakdown of the Company’s gross premiums written by line and class of business, and by geographic area of risks insured for the periods indicated:

Gross Premiums Written by Line of Business
    Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Property
Commercial $ 12,070  7.1  % $ 14,440  9.3  % $ 30,236  7.8  % $ 29,131  8.5  %
Motor 93  0.1  352  0.2  155  —  584  0.2 
Personal 10,614  6.3  16,368  10.6  17,562  4.5  32,005  9.4 
Total Property 22,777  13.5  31,160  20.1  47,953  12.3  61,720  18.1 
Casualty
General Liability 33,741  20.0  27,517  17.8  55,398  14.3  48,076  14.1 
Motor Liability 8,638  5.1  2,707  1.7  14,656  3.8  8,306  2.4 
Professional Liability (448) (0.3) 2,625  1.7  119  —  6,272  1.8 
Workers' Compensation (40) —  3,899  2.5  3,380  0.9  7,058  2.1 
Multi-line 38,314  22.7  51,724  33.4  113,441  29.4  105,884  31.0 
Total Casualty 80,205  47.5  88,472  57.1  186,994  48.4  175,596  51.4 
Other
Accident & Health 2,947  1.7  2,013  1.3  3,878  1.0  4,489  1.3 
Financial 17,945  10.6  8,850  5.7  38,144  9.9  31,347  9.2 
Marine 10,879  6.4  7,854  5.1  30,442  7.9  19,994  5.9 
Other Specialty 34,222  20.3  16,594  10.7  78,822  20.5  48,252  14.1 
Total Other 65,993  39.1  35,311  22.8  151,286  39.3  104,082  30.5 
$ 168,975  100.0  % $ 154,943  100.0  % $ 386,233  100.0  % $ 341,398  100.0  %

Gross Premiums Written by Geographic Area of Risks Insured
  Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
U.S. and Caribbean $ 61,786  36.6  % $ 59,588  38.5  % $ 119,160  30.9  % $ 129,440  37.9  %
Worldwide (1)
90,153  53.4  75,131  48.5  234,462  60.7  181,393  53.1 
Europe
3,792  2.2  3,641  2.3  8,280  2.1  7,068  2.1 
Asia
13,244  7.8  16,583  10.7  24,331  6.3  23,497  6.9 
$ 168,975  100.0  % $ 154,943  100.0  % $ 386,233  100.0  % $ 341,398  100.0  %
(1) “Worldwide” is composed of contracts that reinsure risks in more than one geographic area and may include risks in the U.S. 



21


Item 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
References to “we,” “us,” “our,” “our company,” or “the Company” refer to Greenlight Capital Re, Ltd. (“GLRE”) and its wholly-owned subsidiaries unless the context dictates otherwise.
 
The following discussion should be read in conjunction with the audited consolidated financial statements and accompanying notes, which appear in our 2023 Form 10-K.

The following is management’s discussion and analysis (“MD&A”) of our results of operations for the three and six months ended June 30, 2024 and 2023 and the Company’s financial condition at June 30, 2024 and December 31, 2023 (herein referred as “Q2 2024 Financials”).
  
All amounts are reported in U.S. dollars, unless otherwise noted. Tabular dollars are presented in thousands, with the exception of per share amounts or as otherwise noted.

Page



22


Overview

Business Overview

We are a global specialty property and casualty reinsurer headquartered in the Cayman Islands, with an underwriting and investment strategy that we believe differentiates us from most of our competitors. Our goal is to build long-term shareholder value by providing risk management solutions to the insurance, reinsurance, and other risk marketplaces.

For the second quarter of 2024 (“Q2 2024”) we earned a net income of $8.0 million, a decrease of $41.9 million over the same period in the prior year, principally due to the lower return from our investment in Solasglas and to a lesser extent lower underwriting profits driven by higher CAT losses.

The following is a summary of our financial performance for Q2 2024, compared to the same quarter in 2023 (“Q2 2023”):
•Gross premiums written was $169.0 million, an increase of 9.1%;
•Net premiums earned was $158.4 million, an increase of 13.2%;
•Net underwriting income (1) was $0.3 million, compared to $5.4 million;
•Total CAT losses, net of reinsurance, were $17.9 million, compared to $9.3 million;
•Total investment income was $12.6 million, a decrease of 70.2% (including 1.2% net return from our investment in Solasglas, compared to net return of 10.9%); and
•Diluted EPS was $0.23, compared to $1.32.

Fully diluted book value per share(1) was $17.65 at June 30, 2024, an increase of 5.4% since December 31, 2023.

(1) See “Key Financial Measures and Non-GAAP Measures” section of this MD&A.


Outlook and Trends

The 2024 mid-year renewals have been characterized by a healthy balance of supply and demand of reinsurance capacity. Reinsurance terms and conditions are retaining discipline across a majority of classes, most notably with respect to property excess of loss attachment points. We continue to view the terms and conditions available in the property and specialty market as attractive for growth.

As we approach the peak months of North Atlantic hurricane season, the industry’s attention is drawn to the record set in early July by Hurricane Beryl for the earliest category 5 storm to form in the North Atlantic. Another key focus in the industry is the degree of additional reserve strengthening that may emerge in casualty classes throughout the remainder of the year.

It is likely that terms and conditions in the reinsurance market will be highly dependent on the progression of the above factors throughout the remainder of 2024.



23


Key Financial Measures and Non-GAAP Measures

There have been no changes to our key financial measures, including non-GAAP financial measures, as described in the MD&A of our 2023 Form 10-K.

Fully Diluted Book Value Per Share

The following table presents a reconciliation of the fully diluted book value per share to basic book value per share (the most directly comparable U.S. GAAP financial measure):
June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023
Numerator for basic and fully diluted book value per share:  
Total equity as reported under U.S. GAAP $ 634,020  $ 624,458  $ 596,095  $ 575,865  $ 561,121 
Denominator for basic and fully diluted book value per share:
Ordinary shares issued and outstanding as reported and denominator for basic book value per share 35,321,144 35,321,144 35,336,732 35,337,407 35,272,013
Add: In-the-money stock options (1) and all outstanding RSUs
594,612 585,334 264,870 312,409 312,409
Denominator for fully diluted book value per share 35,915,756 35,906,478 35,601,602 35,649,816 35,584,422
Basic book value per share $ 17.95  $ 17.68  $ 16.87  $ 16.30  $ 15.91 
Increase in basic book value per share ($)
$ 0.27  $ 0.81  $ 0.57  $ 0.39  $ 1.45 
Increase in basic book value per share (%)
1.5  % 4.8  % 3.5  % 2.5  % 10.0  %
Fully diluted book value per share $ 17.65  $ 17.39  $ 16.74  $ 16.15  $ 15.77 
Increase in fully diluted book value per share ($)
$ 0.26  $ 0.65  $ 0.59  $ 0.38  $ 1.43 
Increase in fully diluted book value per share (%)
1.5  % 3.9  % 3.7  % 2.4  % 10.0  %
(1) Assuming net exercise by the grantee.



















24


Net Underwriting Income (Loss)

The reconciliations of net underwriting income (loss) to income (loss) before income taxes (the most directly comparable U.S. GAAP financial measure) on a consolidated basis are shown below:
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Income before income tax $ 8,413  $ 49,888  $ 35,951  $ 55,829 
Add (subtract):
Total investment income (12,554) (42,151) (38,945) (47,391)
Foreign exchange losses (gains) 932  (4,729) 2,581  (9,660)
Other non-underwriting income (2,724) (2,866) (7,759) (5,032)
Corporate expenses 4,706  4,557  9,081  10,554 
Interest expense 1,560  744  2,809  1,520 
Net underwriting income $ 333  $ 5,443  $ 3,718  $ 5,820 

25


Consolidated Results of Operations

The table below summarizes our consolidated operating results for the three and six months ended June 30, 2024 and 2023:
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Underwriting revenue
Gross premiums written $ 168,975  $ 154,943  $ 386,233  $ 341,398 
Gross premiums ceded (14,832) (9,739) (38,013) (20,951)
Net premiums written 154,143  145,204  348,220  320,447 
Change in net unearned premium reserves 4,255  (5,261) (28,286) (37,855)
Net premiums earned $ 158,398  $ 139,943  $ 319,934  $ 282,592 
Underwriting related expenses
Net loss and loss adjustment expenses incurred:
Current year $ 102,722  $ 88,740  $ 206,647  $ 173,428 
Prior year (1)
(689) 1,764  4,712  13,801 
Net loss and loss adjustment expenses incurred 102,033  90,504  211,359  187,229 
Acquisition costs 50,454  38,293  92,064  79,769 
Underwriting expenses 5,811  5,468  12,150  9,407 
Deposit interest expense (income), net
(233) 235  643  367 
Net underwriting income (2)
$ 333  $ 5,443  $ 3,718  $ 5,820 
Income (loss) from investment in Solasglas $ 4,330  $ 32,782  $ 22,578  $ 29,644 
Net investment income 8,224  9,369  16,367  17,747 
Total investment income
$ 12,554  $ 42,151  $ 38,945  $ 47,391 
Corporate expenses $ 4,706  $ 4,557  $ 9,081  $ 10,554 
Foreign exchange losses (gains)
932  (4,729) 2,581  (9,660)
Other income, net (2,724) (2,866) (7,759) (5,032)
Interest expense 1,560  744  2,809  1,520 
Income tax expense 435  28  954  82 
Net income $ 7,978  $ 49,860  $ 34,997  $ 55,747 
Earnings per share:
  Basic $ 0.23  $ 1.46  $ 1.02  $ 1.64 
  Diluted $ 0.23  $ 1.32  $ 1.01  $ 1.49 
Underwriting ratios:
Loss ratio - current year 64.8  % 63.4  % 64.6  % 61.4  %
Loss ratio - prior year (0.4) % 1.3  % 1.5  % 4.9  %
Loss ratio 64.4  % 64.7  % 66.1  % 66.3  %
Acquisition cost ratio 31.9  % 27.4  % 28.8  % 28.2  %
Composite ratio 96.3  % 92.1  % 94.9  % 94.5  %
Underwriting expense ratio 3.5  % 4.1  % 4.0  % 3.5  %
Combined ratio 99.8  % 96.2  % 98.9  % 98.0  %
26


1 The net financial impact associated with changes in the estimate of losses incurred in prior years, which incorporates earned reinstatement premiums assumed and ceded, adjustments to assumed and ceded acquisition costs, and deposit interest income and expense, was a loss of $0.4 million and $1.9 million for the three months ended June 30, 2024 and 2023, respectively, and a loss of $5.8 million and $13.9 million for the six months ended June 30, 2024 and 2023, respectively.

2 Net underwriting income is a non-GAAP financial measure. See “ Key Financial Measures and Non-GAAP Measures” above for discussion and reconciliation of non-GAAP financial measures.


The following provides further details on the significant variances for Q2 2024 compared to same quarter in 2023 (“Q2 2023”) and for the six months ended June 30, 2024 (“YTD 2024”) compared to the same period in 2023 (“YTD 2023”).

Overview

Three months ended June 30, 2024

Fully diluted book value per share increased by $0.26 per share, or 1.5%, to $17.65 per share from $17.39 per share at March 31, 2024. Basic book value per share increased by $0.27 per share, or 1.5%, to $17.95 per share from $17.68 per share at March 31, 2024.

Net income was $8.0 million for Q2 2024, compared to net income of $49.9 million reported for Q2 2023.

The developments that most significantly affected our financial performance during Q2 2024, compared to Q2 2023, are summarized below:

•Underwriting income: Decreased by $5.1 million primarily driven by 3.6 percentage points increase in our combined ratio, predominantly due to higher acquisition costs relating to our FAL business, partially offset by improved loss ratio and underwriting expense ratio. While total CAT losses were higher than in Q2 2023, this was offset by improved attritional loss ratio for our underwriting portfolio during the quarter. Current year CAT losses contributed 8.4% to our combined ratio, compared to 7.3% in Q2 2023. For further information on CAT losses and prior year loss development, refer to Note 7 - Loss and Loss Adjustment Expense Reserves of the Q2 2024 Financials.
•Investment income: Decreased by $29.6 million primarily driven by lower income from Solasglas. Our investment in Solasglas reported a gain of $4.3 million during Q2 2024, compared to a gain of $32.8 million during Q2 2023. Solasglas generated a net return of 1.2% for Q2 2024 compared to a net return of 10.9% for Q2 2023; and
•Foreign exchange gains (losses): $0.9 million foreign exchange losses for Q2 2024, compared to $4.7 million foreign exchange gains in Q2 2023, driven mainly by the strengthening of the pound sterling against the U.S. dollar in Q2 2023 whereby there was no significant movement in Q2 2024.

Six months ended June 30, 2024

Fully diluted book value per share increased by $0.91 per share, or 5.4%, to $17.65 per share from $16.74 per share at December 31, 2023. Basic book value per share increased by $1.08 per share, or 6.4%, to $17.95 per share from 16.87 per share at December 31, 2023.

Net income was $35.0 million for YTD 2024, compared to net income of $55.7 million reported for YTD 2023.

The developments that most significantly affected our financial performance during YTD 2024, compared to YTD 2023, are summarized below:

•Underwriting income: Decreased by $2.1 million primarily driven by 0.9 percentage points increase in our combined ratio mainly due to an increase in acquisition costs (same reason as Q2 2024) and an increase in underwriting expenses. While current year CAT losses contributed 8.0 percentage points to our combined ratio, compared to 5.8 percentage points for YTD 2023, the increase was offset by an improved attritional loss ratio for our underwriting portfolio. For further information on CAT losses and prior year loss development, refer to Note 7 - Loss and Loss Adjustment Expense Reserves of the Q2 2024 Financials.
27


•Investment income: Decreased by $8.4 million primarily driven by lower income from Solasglas. Our investment in Solasglas reported a gain of $22.6 million during YTD 2024, compared to a gain of $29.6 million during the equivalent period in 2023. Solasglas generated a net return of 6.4% for YTD 2024 compared to a net return of 9.7% for YTD 2023 .
•Corporate expense: Decreased by $1.5 million mainly due to non-recurring severance costs included in YTD 2023 and lower outside legal costs following the hiring of our new General Counsel in April 2023.
•Foreign exchange gains (losses): $2.6 million foreign exchange losses for YTD 2024, compared to $9.7 million foreign exchange gains for YTD 2023, driven mainly by the reversal of the pound sterling movement against the U.S. dollar; and
•Other income, net: Increased by $2.7 million due to stronger investment income generated on funds withheld by third party Lloyd’s syndicates, reported on a quarterly lag basis.

Underwriting Results by Segment
The following provides a further discussion of our underwriting results for our Property & Casualty (Re)insurance operating segment for the three and six months ended June 30, 2024 and 2023.

Gross Premiums Written
 
Details of gross premiums written are provided in the following table: 
  Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Property $ 22,777  13.5  % $ 31,160  20.1  % $ 47,953  12.4  % $ 61,720  18.1  %
Casualty 80,205  47.5  88,472  57.1  186,994  48.4  175,596  51.4 
Other 65,993  39.1  35,311  22.8  151,286  39.2  104,082  30.5 
Total $ 168,975  100.0  % $ 154,943  100.0  % $ 386,233  100.0  % $ 341,398  100.0  %

As a result of our underwriting philosophy, the total premiums we write and the mix of premiums between property, casualty, and other business, may vary significantly from period to period depending on the market opportunities we identify.

Our Q2 2024 gross premiums written increased by $14.0 million, or 9.1%, compared to the equivalent 2023 period.

28


The following table provides a further analysis of this overall increase:
Gross Premiums Written
Three months ended June 30, 2024
Increase (decrease)
($ in millions)
% change Explanation
Property $(8.4) (26.9)%
The decrease was driven predominantly by the non-renewal of a U.S. homeowners’ property treaty within Personal class. This was offset partially by growth in the Commercial class driven by new Innovations business. This resulted in a change in business mix for Property, with Commercial and Personal accounting for 53% and 47%, respectively, of total Property compared to 46% and 53%, respectively, for the same quarter in 2023.
Casualty $(8.3) (9.3)%
The decrease was driven predominantly from revision to estimated ultimate gross premiums for certain 2023 and 2024 FAL treaties, partially offset by growth experienced by Syndicate 3456, within the Multi-line class.
Additionally, we revised the estimated premiums for certain prior years’ quota share treaties within Professional and Workers’ Compensation classes of business. This reduction in Casualty premiums was partially offset by growth in the General Liability class from 2023 quota share treaties and new business in 2024. Further, Motor Liability premium increased mainly due to new excess of loss treaties.

As a result, the business mix within our Casualty line of business has changed with General Liability, Motor Liability, and Multi-line classes accounting for 42%, 11%, and 48% of total Casualty, respectively, compared to 31%, 3%, and 58% in the same period in 2023.
Other $30.7 86.9%
The increase was driven predominantly by new business in our Marine and Energy class, including Lloyd’s whole account excess of loss treaties.

Our YTD 2024 gross premiums written increased by $44.8 million, or 13.1%, compared to the equivalent 2023 period.

The following table provides a further analysis of this overall increase:
Gross Premiums Written
Six months ended June 30, 2024
Increase (decrease)
($ in millions)
% change Explanation
Property $(13.8) (22.3)%
Same trends as noted for Q2 2024. This resulted in a change in business mix for Property, with Commercial and Personal accounting for 53% and 47%, respectively, of total Property compared to 46% and 53%, respectively, for the same period in 2023.
Casualty $11.4 6.5%
The increase was due to growth in the General Liability and Motor Liability classes of business as noted for Q2 2024, coupled with an overall net increase in Multi-Line class, driven mainly by growth in our Syndicate 3456. The growth in Motor Liability class is predominantly from new excess of loss treaties.

The above growth was partially offset by revision to estimated ultimate gross premiums for certain 2023 and 2024 FAL treaties and by lower premiums for Professional and Workers’ Compensation classes of business.

General Liability and Multi-line classes accounted for 30% and 61%, respectively, of total Casualty, compared to 27% and 60%, respectively, in the same period in 2023.
Other $47.2 45.4%
Same trends as noted for Q2 2024.
29



Premiums Ceded
 
For Q2 2024, premiums ceded were $14.8 million, or 8.8% of gross premiums written, compared to $9.7 million, or 6.3% of gross premiums written, for the same quarter in 2023. For YTD 2024, premiums ceded were $38.0 million, or 9.8% of gross premiums written, compared to $21.0 million, or 6.1% of gross premiums written, for YTD 2023.

The increase in both periods was primarily due to the purchase of an additional retrocessional coverage to manage our overall exposure to Marine and Energy class in light of recent growth in this class of business and to reinstate certain retro excess of loss treaties in which the full coverage was presumed exhausted primarily from the Baltimore bridge loss event. Additionally, we had an increase in quota share retrocessions for Other Specialty business due to growth from inward premiums.

Net Premiums Written

Details of net premiums written are provided in the following table: 
  Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Property $ 16,855  10.9  % $ 26,433  18.2  % $ 38,059  10.9  % $ 52,626  16.4  %
Casualty 77,431  50.2  84,840  58.4  176,881  50.8  172,036  53.7 
Other 59,857  38.8  33,931  23.4  133,280  38.3  95,785  29.9 
Total $ 154,143  100.0  % $ 145,204  100.0  % $ 348,220  100.0  % $ 320,447  100.0  %

For Q2 2024 and YTD 2024, net premiums written increased by $8.9 million, or 6.2%, and $27.8 million or 8.7%, respectively, compared to the same periods in 2023. The movement in net premiums written resulted from the changes in gross premiums written and ceded during the periods as previously noted.

Net Premiums Earned
 
Details of net premiums earned are provided in the following table: 
  Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Property $ 18,119  11.4  % $ 20,749  14.8  % $ 41,476  13.0  % $ 39,492  14.0  %
Casualty 86,155  54.4  81,446  58.2  180,793  56.5  165,561  58.6 
Other 54,124  34.2  37,748  27.0  97,665  30.5  77,539  27.4 
Total $ 158,398  100.0  % $ 139,943  100.0  % $ 319,934  100.0  % $ 282,592  100.0  %

Net premiums earned for Q2 2024 and YTD 2024, increased by $18.5 million or 13.2%, and by $37.3 million or 13.2%, respectively, compared to the same periods in 2023. The change in net premiums earned is primarily a function of the amount and timing of net premiums written during the current and prior periods, coupled with the mix of business written in the form of excess of loss versus proportional contracts. For Q2 2024 and YTD 2024, excess of loss treaties accounted for 16% and 15% of the total net premiums earned, respectively, compared to 14% and 13% for Q2 2023 and YTD 2023, respectively.

30


Loss and LAE Incurred, Net
 
The components of the loss ratio were as follows:
Three months ended June 30 Six months ended June 30
  2024 2023 Increase / (decrease) in loss ratio points 2024 2023 Increase / (decrease) in loss ratio points
Current accident year loss ratio 64.8  % 63.4  % 1.4  64.6  % 61.4  % 3.2 
Prior year reserve development ratio (0.4) % 1.3  % (1.7) 1.5  % 4.9  % (3.4)
Loss ratio 64.4  % 64.7  % (0.3) 66.1  % 66.3  % (0.2)

For Q2 2024 and YTD 2024, our total loss ratio improved by 0.3 and 0.2 percentage points, respectively, compared to the same periods in 2023.
Current accident year loss ratio increased by 1.4 percentage points for Q2 2024, compared to the same quarter in 2023 driven mainly by 1.3 points increase in CAT losses. This increase was driven predominantly by the severe U.S. tornados (including convective storms).
Current accident year loss ratio increased by 3.2 percentage points for YTD 2024, compared to the same period in 2023, driven by 2.2 points increase in CAT loss events, mainly due to the Baltimore bridge loss and the severe U.S. tornados. While we have not renewed a U.S. homeowners’ property program in 2024, we wrote and earned premiums from the 2023 quota share treaty during 2024.
For the current quarter, we had prior year favorable loss development of 0.4%, compared to adverse loss development of 1.3% for the same quarter in 2023. For YTD 2024, our prior year adverse loss development improved by 3.4 percentage points compared to the same period in 2023. Refer to Note 7 for further details on prior year loss development.
Details of net losses incurred by line of business are provided in the following table:

  Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Property $ 21,155  20.7  % $ 21,402  23.6  % $ 33,133  15.7  % $ 38,932  20.8  %
Casualty 58,581  57.3  49,608  54.8  118,598  56.1  110,646  59.1 
Other 22,297  22.0  19,494  21.6  59,628  28.2  37,651  20.1 
Total $ 102,033  100.0  % $ 90,504  100.0  % $ 211,359  100.0  % $ 187,229  100.0  %

The below table summarizes the loss ratios by line of business:
Three months ended June 30 Six months ended June 30
  2024 2023 Increase / (decrease) in loss ratio points 2024 2023 Increase / (decrease) in loss ratio points
Property 116.8  % 103.1  % 13.7  79.9  % 98.6  % (18.7)
Casualty 68.0  60.9  7.1  65.6  66.8  (1.2)
Other 41.2  51.6  (10.4) 61.1  48.6  12.5 
Total 64.4  % 64.7  % (0.3) 66.1  % 66.3  % (0.2)
31


The following provides further details on the change in Q2 2024 vs. Q2 2023.
Net Losses Incurred
Three months ended June 30, 2024
Increase (decrease)
($ in millions)
Increase / (decrease) in loss ratio points  
Property $(0.2) 13.7
The marginal decrease in losses incurred was driven by the 12.7% decrease in net premiums earned, offset partially by an increase of $0.3 million in current CAT losses mainly from U.S. tornados and to a lesser extent from German floods.

The increase in loss ratio points is driven mainly by the higher attritional and CAT losses from a U.S. homeowners’ property program which was non-renewed in 2024.
Casualty $9.0 7.1
Driven by the 5.8% increase in net premiums earned, coupled with an increase in prior year adverse loss development, which contributed 7.1 percentage points to the loss ratio. This was predominantly driven by our legacy Multiline and Workers’ Compensation exposures.
Other $2.8 (10.4)
Driven by the 43.4% increase in net premiums earned, offset partially by favorable prior year loss development, mainly in our Mortgage and Marine and Energy classes of business. This contributed 16.8 percentage points to the reduction in the loss ratio. However, offsetting this benefit, our current attritional loss ratio increased for the Marine class in 2024 compared 2023.

The following provides further details on the change in YTD 2024 vs. YTD 2023.
Net Losses Incurred
Six months ended June 30, 2024
Increase (decrease)
($ in millions)
Increase / (decrease) in loss ratio points  
Property $(5.8) (18.7)
Despite the 5.0% increase in net premiums earned, the losses incurred and loss ratio decreased predominantly due to the 16.6 percentage points decrease in property-related CAT losses compared to YTD 2023.
Casualty $8.0 (1.2)
The increase in losses incurred was driven by the 5.8% increase in net premiums earned.

The improvement in loss ratio was driven by lower prior year adverse loss development, which contributed 4.3 percentage points. This was primarily driven from significant adverse loss development in our legacy Motor class in 2023, whereas we had favorable loss development for this class in 2024.
Other $22.0 12.5
The increase in losses incurred was driven by the 26.0% increase in net premiums earned, coupled with higher CAT losses.

The current year CAT losses contributed 14.5 percentage points to the total loss ratio, which was driven by the Baltimore bridge collapse and satellite failures. The change in business mix also contributed to the increase in loss ratio. This was partially offset by 6.4 percentage points from prior year favorable loss development, primarily in our Mortgage and Marine and Energy classes of business.

Acquisition Costs, Net

For Q2 2024 and YTD 2024, our total acquisition costs increased by 31.8% to $50.5 million, and by 15.4% to $92.1 million, respectively, compared to the same periods in 2023, mainly due to growth in net premiums earned and higher commissions, predominantly in our Casualty and Other lines of business. The acquisition cost ratios by line of business were as follows:
32


  Three months ended June 30 Six months ended June 30
  2024 2023 Increase / (decrease) in acquisition cost ratio points 2024 2023 Increase / (decrease) in acquisition cost ratio points
Property 10.7  % 19.1  % (8.4) % 15.8  % 19.1  % (3.3) %
Casualty 36.9  30.5  6.4  32.0  30.5  1.5 
Other 31.0  25.1  5.9  28.3  28.1  0.2 
Total 31.9  % 27.4  % 4.5  % 28.8  % 28.2  % 0.6  %

The following provides further details on the change in Q2 2024 vs. Q2 2023.
Change in Acquisition Cost Ratios
Three months ended June 30, 2024
  Increase / (decrease) in acquisition cost ratio points Explanation
Property (8.4)
The decrease was driven by the change in business mix as a result of not renewing a U.S. homeowner’s program that had a higher acquisition cost ratio compared to the increase in net premiums earned from CAT retro quota share treaties at lower acquisition costs.
Casualty 6.4
The increase was driven primarily due to higher than previously estimated acquisition costs for certain 2023 and 2024 FAL business within our Multi-line class. This was partially offset by a change in business mix, particularly with growth in net premiums earned from General Liability and Motor Liability classes of business at lower acquisition costs.
Other 5.9
The increase was driven primarily by the prior year favorable loss reserve releases during the quarter for certain mortgage programs within our Financial class, which resulted in higher performance-based commission costs. There was no comparable favorable loss reserves release for this business in Q2 2023, which would have triggered additional commission costs.
    
The following provides further details on the change in YTD 2024 vs. YTD 2023.
Change in Acquisition Cost Ratios
Six months ended June 30, 2024
  Increase / (decrease) in acquisition cost ratio points Explanation
Property (3.3)
Same trends as noted for Q2 2024.
Casualty 1.5
Same trends as noted for Q2 2024.
Other 0.2
Same trends as noted for Q2 2024. However, this was offset partially by the change in business mix as a result of the growth in our Marine and Energy class at lower acquisition costs.
33



Ratio Analysis
 
The following table provides our underwriting ratios by line of business for the respective periods: 


Three months ended June 30 Three months ended June 30
2024 2023
Property Casualty Other Total Property Casualty Other Total
Loss ratio 116.8  % 68.0  % 41.2  % 64.4  % 103.1  % 60.9  % 51.6  % 64.7  %
Acquisition cost ratio 10.7  36.9  31.0  31.9  19.1  30.5  25.1  27.4 
Composite ratio 127.5  % 104.9  % 72.2  % 96.3  % 122.2  % 91.4  % 76.7  % 92.1  %
Underwriting expense ratio 3.5  4.1 
Combined ratio 99.8  % 96.2  %

Our combined ratio increased by 3.6 percentage points for the current quarter compared to Q2 2023 predominantly due to higher acquisition cost ratio; partially offset by a decrease in loss ratio and underwriting expense ratio. The underwriting expense ratio improved as a result of higher volume of net premium earned to cover underwriting expenses and, to a lesser extent, a net gain from deposit-accounted contracts as a result of a favorable commutation during the quarter.

Six months ended June 30 Six months ended June 30
2024 2023
Property Casualty Other Total Property Casualty Other Total
Loss ratio 79.9  % 65.6  % 61.1  % 66.1  % 98.6  % 66.8  % 48.6  % 66.3  %
Acquisition cost ratio 15.8  % 32.0  % 28.3  % 28.8  % 19.1  % 30.5  % 28.1  % 28.2  %
Composite ratio 95.7  % 97.6  % 89.4  % 94.9  % 117.7  % 97.3  % 76.7  % 94.5  %
Underwriting expense ratio 4.0  % 3.5  %
Combined ratio 98.9  % 98.0  %

Our combined ratio increased by 0.9 percentage points for YTD 2024 compared to same period in 2023 predominantly due to higher acquisition cost ratio and underwriting expense ratio (see G&A Expenses below for further details); partially offset by a decrease in loss ratio.

General and Administrative (“G&A”) Expenses

The breakdown of our G&A expenses between underwriting and corporate functions was as follows:
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Underwriting expenses $ 5,811  $ 5,468  $ 12,150  $ 9,407 
Corporate expenses 4,706  4,557  9,081  10,554 
General and administrative expenses $ 10,517  $ 10,025  $ 21,231  $ 19,961 
G&A increased by 4.9% for Q2 2024, compared to Q2 2023. The increase was driven by:

•Underwriting expenses: Increased by $0.3 million or 6.3%, predominantly due to an increase in headcount to drive business growth, coupled with an increase in professional fees and outsourced services relating to underwriting activities. Further, Q2 2023 included a bad debt charge of $0.6 million, with no similar charge during Q2 2024.

•Corporate expenses: No significant change for the quarter.
34



G&A increased by 6.4% for YTD 2024, compared to same period in 2023. The increase was driven by:

•Underwriting expenses: Increased by $2.7 million or 29.2%, predominantly due to an increase in headcount to drive business growth, coupled with an increase in professional fees and outsourced services relating to underwriting activities. As a result, this contributed to the net increase in underwriting expense ratio in the YTD 2024 compared to the same period in 2023.

•Corporate expenses: Decreased by $1.5 million or 14.0%, driven mainly by non-recurring severance costs included in YTD 2023 and lower outside legal costs following the hiring of our new General Counsel in April 2023.

Total Investment Income

A summary of our total investment income is as follows:
Three months ended June 30 Six months ended June 30
  2024 2023 2024 2023
Interest and dividend income, net of withholding taxes and other expenses 8,135  8,863  $ 16,691  $ 17,491 
Net realized and unrealized gains on other investments (see Note 4) 89  506  (324) 256 
Net investment-related income
$ 8,224  $ 9,369  $ 16,367  $ 17,747 
Share of Solasglas' net income (see Note 3) 4,330  32,782  22,578  29,644 
Total investment income $ 12,554  $ 42,151  $ 38,945  $ 47,391 

Net investment-related income

Our net investment-related income decreased by 8.2% compared to Q2 2023, and by 4.6% compared to YTD 2023, mainly driven by the decrease in interest income earned from restricted cash and cash equivalents as a result of decreases in the outstanding collateral balance during both periods.

Share of Solasglas’ net income

For Q2 2024 and YTD 2024, Solasglas reported a gain of 1.2% and 6.4%, respectively, compared to a gain of 10.9% and 9.7% for Q2 2023 and YTD 2023, respectively. The following table provides a breakdown of the gross and net investment return for Solasglas.
Three months ended June 30 Six months ended June 30
2024 2023 2024 2023
Long portfolio gains (losses) (1.0) % 18.0  % 3.4  % 27.3  %
Short portfolio gains (losses) 1.6  (5.5) 1.7  (14.8)
Macro gains (losses) 0.9  0.3  2.9  (0.1)
Other income and expenses 1
(0.2) (0.8) (0.9) (1.6)
Gross investment return 1.3  % 12.0  % 7.1  % 10.8  %
Net investment return 1
1.2  % 10.9  % 6.4  % 9.7  %

1 “Other income and expenses” excludes performance compensation but includes management fees. “Net investment return” incorporates both of these amounts. For further information about management fees and performance compensation, refer to Note 3.

For Q2 2024, the significant contributors to Solasglas’ investment return were long positions in Solvay (Belgium: SOLB), HP (HPQ), and Kyndryl Holdings (KD). The largest detractors were long positions in Brighthouse Financial (BHF), Green Brick Partners (GRBK), and a single-name short position.

For YTD 2024, the significant contributors to Solasglas’ investment return were long positions in GRBK, gold, and Tenet Healthcare (THC). The largest detractors were a long position in BHF and two single-name short positions.

35


Each month, we post on our website (www.greenlightre.com) the returns from our investment in Solasglas.

Financial Condition
 
Investments
 
The following table provides a breakdown of our total investments: 
June 30 December 31
2024 2023
Investment in related party investment fund (Solasglas)
$ 351,468  82.8  % $ 258,890  78.0  %
Other investments:
Private investments and unlisted equities
71,866  16.9  71,157  21.4 
  Debt and convertible debt securities 1,293  0.3  2,136  0.6 
Total other investments
$ 73,159  17.2  % $ 73,293  22.0  %
Total investments $ 424,627  100.0  % $ 332,183  100.0  %

At June 30, 2024, our total investments increased by $92.4 million, or 27.8%, to $424.6 million from December 31, 2023. The increase was primarily driven by $70.0 million of additional contributions into Solasglas, coupled with the net investment return for Q2 2024. The contributions were funded partially from cash flow from operations and partially from the release of restricted cash.

Investments in Solasglas

DME Advisors reports the composition of Solasglas’ portfolio on a delta-adjusted basis, which it believes is the appropriate manner to assess the exposure and profile of investments and reflects how it manages the portfolio. An option’s delta is the option price’s sensitivity to the underlying stock (or commodity) price. The delta-adjusted basis is the number of shares or contracts underlying the option multiplied by the delta and the underlying stock (or commodity) price.
  
The following table represents the composition of Solasglas’ investments:
June 30 December 31
2024 2023
Long % Short % Long % Short %
Equities and related derivatives 79.4  % 38.2  % 90.2  % 53.8  %
Private and unlisted equity securities 2.0  —  2.0  — 
Debt instruments 0.3  —  0.3  — 
Total 81.7  % 38.2  % 92.5  % 53.8  %

The above exposure analysis does not include cash (U.S. dollar and foreign currencies), gold and other commodities, credit default swaps, sovereign debt, foreign currency derivatives, interest rate derivatives, inflation swaps and other macro positions. Under this methodology, a total return swap’s exposure is reported at its full notional amount and options are reported at their delta-adjusted basis. At June 30, 2024, Solasglas’ exposure to gold on a delta-adjusted basis was 7.5% (2023: 11.2%).

At June 30, 2024, 94.3% of Solasglas’ portfolio was valued based on quoted prices in actively traded markets (Level 1), 4.1% was composed of instruments valued based on observable inputs other than quoted prices (Level 2), and a nominal amount was composed of instruments valued based on non-observable inputs (Level 3). At June 30, 2024, 1.6% of Solasglas’ portfolio consisted of private equity funds valued using the funds’ net asset values as a practical expedient.

36


Other Investments

The other investment holdings relate to private investments made by Innovations. During Q2 2024, we made two modest private equity investments. During the YTD 2024, we impaired certain debt securities (see Note 4), resulting in a decrease in the carrying value of these securities.

Restricted cash and cash equivalents

We use our restricted cash and cash equivalents primarily for funding trusts and letters of credit issued to our ceding insurers. Our restricted cash decreased by $42.7 million, or 7.1%, from $604.6 million at December 31, 2023, to $561.9 million at June 30, 2024, primarily due to release of collateral from our ceding insurers relating to legacy contracts in run-off.

Reinsurance balances receivable

Our reinsurance balances receivable increased by $67.3 million, or 10.9%, to $686.7 million from $619.4 million at December 31, 2023. This increase was driven primarily by the renewal of reinsurance treaties, in addition to new business bound during 2024.
Loss and LAE Reserves; Loss and LAE Recoverable

Our reserves for loss and LAE by lines of business were as follows: 
  June 30, 2024 December 31, 2023
  Case
Reserves
IBNR Total Case
Reserves
IBNR Total
Property $ 33,531  $ 49,708  $ 83,239  $ 24,181  $ 41,056  $ 65,237 
Casualty 139,286  317,563  456,849  136,713  299,933  436,646 
Other 37,985  174,684  212,669  28,156  131,515  159,671 
Total $ 210,802  $ 541,955  $ 752,757  $ 189,050  $ 472,504  $ 661,554 

Our total gross loss and LAE reserves increased by $91.2 million, or 13.8%, to $752.8 million from $661.6 million at December 31, 2023. This increase is primarily driven by the increase in earned premium from the renewal of reinsurance treaties and new business, offset partially by paid losses during Q2 2024. See Note 7 “Loss and Loss Adjustment Expense Reserves” of the financial statements for a summary of changes in outstanding loss and LAE reserves and a description of prior period loss developments.

Our total loss and LAE recoverable increased by $33.0 million, or 128.3%, to $58.6 million from $25.7 million at December 31, 2023. This increase was driven mainly by the loss recoveries on the Baltimore bridge loss event, the Taiwan earthquake (gross losses were mostly retroceded), and the increase in quota share retrocessions for Other Specialty business due to growth from inward premiums. See Note 8 “Retrocession” of the financial statements for a description of the credit risk associated with our retrocessionaires.

Probable Maximum Loss (“PML”)

At July 1, 2024, our estimated largest PML at a 1-in-250-year return period for a single event, and in aggregate, was $99.9 million and $109.2 million, respectively, both relating to the peril of North Atlantic Hurricane, compared to $103.3 million and $111.5 million, respectively, at April 1, 2024.
37



The below table contains the expected modeled loss for each of our peak peril regions and sub-regions for both a single event loss and aggregate loss measures at the 1-in-250-year return period.

July 1, 2024
Net 1-in-250 Year Return Period
Peril Single Event Loss Aggregate Loss
North Atlantic Hurricane $ 99,856  $ 109,207 
Southeast Hurricane 94,455  94,455 
Gulf of Mexico Hurricane 52,552  52,715 
Northeast Hurricane 54,688  55,167 
North America Earthquake 95,487  96,748 
California Earthquake 83,828  86,690 
       Pacific Northwest Earthquake
49,540  49,540 
Other N.A. Earthquake 48,328  48,391 
Japan Earthquake 37,941  38,491 
Japan Windstorm 22,120  23,419 
Europe Windstorm 60,870  64,018 

Debt

Our total debt decreased by $11.7 million, or 15.9%, to $61.6 million from $73.3 million at December 31, 2023 due to partial repayment. Refer to Note 9 “Debt and Credit Facilities” of the financial statements for further information.

Total shareholders’ equity
 
Total shareholders’ equity increased by $37.9 million to $634.0 million, compared to $596.1 million at December 31, 2023. The increase was primarily due to the net income of $35.0 million reported for the period. For details of other movements in shareholders’ equity, see the condensed consolidated statements of shareholders’ equity.
38


Liquidity and Capital Resources

Refer to the “Liquidity and Capital Resources” section included in Item 7 of our 2023 Form 10-K for a general discussion of our liquidity and capital resources.

Liquidity
   
The following table summarizes our sources and uses of funds:
Six months ended June 30
2024 2023
Total cash provided by (used in):
Operating activities $ 40,669  $ 566 
Investing activities (70,246) (7,049)
Financing activities (11,876) (17,085)
Effect of currency exchange on cash(1)
(107) 351 
Net cash inflows (outflows) (41,560) (23,217)
Cash, beginning of period 655,730  706,548 
Cash, end of period $ 614,170  $ 683,331 
(1) Cash includes unrestricted and restricted cash and cash equivalents - see Note 5 of the financial statements.

Cash provided by operating activities

The increase in cash provided by operating activities was driven mainly by the ebb and flow from our underwriting activities, which may vary significantly from period to period depending on the mix of business, the nature of underwriting opportunities available and volume of claims submitted to us by our cedents.

Cash used in investing activities

The increase in cash used for investing activities was driven mainly by the net change in our investment in Solasglas where we made a net contribution of $70.0 million for YTD 2024 compared to a net contribution of $9.0 million during the same period in 2023.

Cash used in financing activities

The decrease in cash used in our financing activities was driven mainly by the repurchase of a portion of the outstanding Convertible Notes in the first half of 2023. In Q2 2024, we partially repaid $11.7 million of the Term loans.

Capital Resources

The following table summarizes our debt and capital structure:

  June 30, 2024 December 31, 2023
Debt
$ 62,188  $ 74,062 
Shareholders’ equity
$ 634,020  $ 596,095 
Ratio of debt to shareholders’ equity
9.7  % 12.4  %

The debt to shareholders’ equity provides an indication of our leverage and capital structure, along with some insights into our financial strength. In addition to the above capital, we also have LOC facilities to support our reinsurance business operations where we are not licensed or admitted as a reinsurer.

Our shareholders’ equity increased in YTD 2024 primarily due to net income for the period.

39


Ordinary Shares

At June 30, 2024, there were 35,321,144 outstanding ordinary shares, a decrease of 15,588 since December 31, 2023, due to forfeited performance restricted shares net of issuance of ordinary shares for vested RSUs.

We did not repurchase any ordinary shares for the six months ended June 30, 2024.

We expect that the existing capital base and internally generated funds will be sufficient to implement our business strategy for the foreseeable future. However, to provide us with flexibility and timely access to public capital markets should we require additional capital for working capital, capital expenditures, acquisitions, or other general corporate purposes, we have renewed our $200.0 million shelf registration by filing the Form S-3 registration statement with the SEC, which became effective on July 5, 2024, and will expire on July 1, 2027.  

Secured LOC Facilities

    As disclosed in Note 9 “Debt and Credit Facilities” of Q2 2024 Financials, the $275 million committed capacity under the Citi LOC agreement will terminate on August 20, 2024. However, Citi informed the Company that it intends to continue providing the Citi LOC on an uncommitted basis for the foreseeable future following the termination date.

Contractual Obligations and Commitments
 
At June 30, 2024, our contractual obligations and commitments by period due were as follows: 
Less than
 1 year
1-3 years 3-5 years More than
 5 years
Total
Operating activities
  Loss and loss adjustment expense reserves (1)
$ 357,560  $ 238,624  $ 88,825  $ 67,748  $ 752,757 
  Operating lease obligations
686  726  —  —  1,412 
Financing activities
  Debt (2)
2,813  59,375  —  —  62,188 
Total
$ 361,059  $ 298,725  $ 88,825  $ 67,748  $ 816,357 
(1) Due to the nature of our reinsurance operations, the amount and timing of the cash flows associated with our reinsurance contractual liabilities will fluctuate, perhaps materially, and, therefore, are highly uncertain.
(2) See Note 9 “Debt and Credit Facilities” of the financial statements.


Critical Accounting Estimates
 
Our financial statements contain certain amounts that are inherently subjective and have required management to make assumptions and best estimates to determine reported values. If certain factors, including those described in “Part II. Item 1A. Risk Factors” included in our 2023 Form 10-K, cause actual events or results to differ materially from our underlying assumptions or estimates. In that case, there could be a material adverse effect on our results of operations, financial condition, or liquidity. The most significant estimates relate to: premium revenues and risk transfer, loss and loss adjustment expense reserves, investment impairments, allowances for credit losses, and share-based compensation.

We believe that the critical accounting estimates discussion in “Part II. Item 7. — Management’s Discussion and Analysis of Financial Condition and Results on Operations” of our 2023 Form 10-K continues to describe the significant estimates and judgments included in the preparation of these financial statements.

Recent Accounting Pronouncements

At June 30, 2024, there were no recently issued accounting pronouncements that we have not yet adopted that we expect could have a material impact on our results of operations, financial condition, or liquidity. See Note 2 “Significant Accounting Policies” of the Q2 2024 Financials.

40


Item 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Refer to Item 7A included in our 2023 Form 10-K. There have been no material changes to this item since December 31, 2023.

Item 4. CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
As required by Rules 13a-15 and 15d-15 of the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports prepared in accordance with the rules and regulations of the SEC is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
 
Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s disclosure controls and procedures will prevent all errors and all frauds. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
 
Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.  
  
Changes in Internal Control Over Financial Reporting
 
There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal controls over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.


41


PART II — OTHER INFORMATION
 
Item 1.    LEGAL PROCEEDINGS
 
From time to time, in the normal course of business, we may be involved in formal and informal dispute resolution procedures, which may include arbitration or litigation, the outcomes of which determine our rights and obligations under our reinsurance contracts and other contractual agreements. In some disputes, we may seek to enforce our rights under an agreement or to collect funds owing to us. In other matters, we may resist attempts by others to collect funds or enforce alleged rights. While the final outcome of legal disputes cannot be predicted with certainty, we do not believe that any of our existing contractual disputes, when finally resolved, will have a material adverse effect on our business, financial condition or operating results. 
 
Item 1A. RISK FACTORS
 
Factors that could cause our actual results to differ materially from those in this report are any of the risks described in “Part I. Item 1A. Risk Factors” included in our 2023 Form 10-K, as filed with the SEC on March 5, 2024. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of June 30, 2024, there have been no other material changes to the risk factors disclosed in “Part I. Item 1A. Risk Factors” included in our 2023 Form 10-K. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 
 
Our Board has adopted a share repurchase plan. The timing of such repurchases and the actual number of shares repurchased will depend on various factors, including price, market conditions, and applicable regulatory and corporate requirements. On May 3, 2024, our Board of Directors re-approved the share repurchase plan until June 30, 2025, authorizing us to repurchase up to $25.0 million of ordinary shares or securities convertible into ordinary shares in the open market, through privately negotiated transactions or Rule 10b5-1 stock trading plans. Any shares repurchased are canceled immediately upon repurchase. We are not required to repurchase any of the ordinary shares. The repurchase plan may be modified, suspended, or terminated at the election of our Board of Directors at any time without prior notice.

There were no share repurchases made under the plan during the three months ended June 30, 2024.

Item 3.    DEFAULTS UPON SENIOR SECURITIES 
 
None.
 
Item 4.    MINE SAFETY DISCLOSURES

Not applicable.
 

Item 5.    OTHER INFORMATION

(c) Insider Trading Arrangements and Related Disclosures

Our directors and executive officers may purchase or sell shares of our ordinary shares in the market from time to time, including pursuant to equity trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”) and in compliance with guidelines specified by the Company. In accordance with Rule 10b5-1 and our insider trading policy, directors, officers, and certain employees who, at such time, are not in possession of material non-public information about the Company are permitted to enter into written plans that pre-establish amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s equity plans (“Rule 10b5-1 Trading Plans”). Under Rule 10b5-1 Trading Plan, a broker executes trades pursuant to parameters established by the director or executive officer when entering into the plan, without further direction from them.

42


During the three months ended June 30, 2024, we did not have any Rule 10b5-1 trading arrangements or any “non-Rule 10b5-1 arrangements” (as defined in Item 408(a) of Regulation S-K) in place for our directors and officers.
 
Item 6.    EXHIBITS

10.1
31.1
31.2
32.1
32.2
101
The following materials from the Company’s Quarterly Report on Form 10-Q for the three and six months ended June 30, 2024 formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Changes in Shareholders’ Equity; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Furnished herewith.
 
 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  GREENLIGHT CAPITAL RE, LTD.
  (Registrant)
  By: /s/ GREGORY RICHARDSON
  Gregory Richardson
Director and Chief Executive Officer
(principal executive officer)
  August 6, 2024
  By: /s/ FARAMARZ ROMER
  Faramarz Romer
Chief Financial Officer
(principal financial and accounting officer)
  August 6, 2024
43
EX-31.1 2 glre-20240630exhibit311.htm EX-31.1 Document

EXHIBIT 31.1  

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Gregory Richardson, certify that:
1.
I have reviewed this quarterly report report on Form 10-Q of Greenlight Capital Re, Ltd.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   

Dated: August 6, 2024 /s/ GREGORY RICHARDSON
    Gregory Richardson
Chief Executive Officer
(principal executive officer)
   

EX-31.2 3 glre-20240630exhibit312.htm EX-31.2 Document

 EXHIBIT 31.2 

CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.

I, Faramarz Romer, certify that:
1.
I have reviewed this quarterly report report on Form 10-Q of Greenlight Capital Re, Ltd.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.   


Dated: August 6, 2024 /s/ FARAMARZ ROMER
    Faramarz Romer
    Chief Financial Officer
(principal financial officer)

EX-32.1 4 glre-20240630exhibit321.htm EX-32.1 Document

EXHIBIT 32.1   
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the "Form 10-Q") for the period ended June 30, 2024 of Greenlight Capital Re, Ltd. (the "Issuer"). 

I, Gregory Richardson, the Principal Executive Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 


Dated: August 6, 2024 /s/ GREGORY RICHARDSON
    Gregory Richardson
Chief Executive Officer
(principal executive officer)
 


EX-32.2 5 glre-20240630exhibit322.htm EX-32.2 Document

EXHIBIT 32.2  
CERTIFICATION OF
CHIEF FINANCIAL OFFICER OF
GREENLIGHT CAPITAL RE, LTD.  


This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the quarterly report on Form 10-Q (the ‘‘Form 10-Q’’) for the period ended June 30, 2024 of Greenlight Capital Re, Ltd. (the ‘‘Issuer’’). 

I, Faramarz Romer, the Principal Financial Officer of the Issuer, certify that to the best of my knowledge: 

1. The Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)), as amended; and 

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.  


Dated: August 6, 2024 /s/ FARAMARZ ROMER
    Faramarz Romer
Chief Financial Officer
(principal financial officer)